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1 GENERAL INTRODUCTION 
1.1 Aim and relevance of the study 
One of the most striking advances achieved recently in the 
field of research of neuromuscular disorders has been the discovery 
of the gene related to the human X-linked Duchenne (DMD) and 
Becker (BMD) muscular dystrophies, together with the 
characterization of the gene product involved. This product that has 
been termed dystrophin is a high molecular weight protein ( « 400 
kDal) of considerable length (about 150 nm; Hoffman et al, 1987). 
Although dystrophin occurs in a number of tissues such as lung, 
kidney and brain (Chelly et al, 1988), it is abundantly present in 
skeletal muscle fibres. Since it was found that dystrophin shares 
many features with a-actinin and spectrin (Davidson and Critchey, 
1988), it has been suggested that dystrophin must be considered to 
be a cytoskeletal protein. 
Histochemical studies in particular have revealed that 
dystrophin is associated with the cytoplasmic side of the muscle 
fibre membrane or sarcolemma (Watkins et al, 1988). This 
important finding focusses renewed attention on the muscle fibre 
surface membrane as a key element in the pathology of muscular 
dystrophy; i.e. in bringing about muscle fibre degeneration and 
necrosis. It has therefore been suggested that the function of 
dystrophin in normal skeletal muscle fibres is to protect the 
membrane against the stresses associated with contraction of (over-
) stretching, simply by providing mechanical strength for the 
sarcolemma (Zubrzycka et al, 1988). However, the precise 
function of dystrophin in the maintenance of the integrity of the 
muscle fibre membrane, as well as the cascade of events that lead 
from a surface membrane defect to muscle fibre necrosis are as yet 
not fully understood. Data are available to suggest that Ca++-ion 
influx into the myofibre plays a crucial role in inducing the cell 
damage, presumably by activation proteinases, phospholipases and 
free-radical catalyzed reactions (for review: see Martonosi, 1989). 
Dystrophin also appears to be missing also in mdx mice, 
11 
which suffer from an X-linked skeletal muscle dystrophy. From a 
genetic point of view, therefore, this animal model closely 
approaches the DMD/BMD type of human muscular dystrophy. On 
the other hand, despite conformity in the absence of dystrophin in 
DMD and the max dystrophy, the two conditions are both clinically 
and pathologically very different. For example, mouse max 
dystrophy, contrary to human DMD, is not fatal. More 
specifically, mdx mice exhibit no obvious muscle weakness at any 
point in their normal life span (Coulton et al, 1988a) After a phase 
of widespread muscle fibre necrosis at age 3-5 weeks, the muscles 
of these animals successfully regenerate and return to normal size 
and strength (Dangain and Vrbova, 1984). In DMD, the process of 
muscle fibre regeneration appears to be progressively less 
successful. From a pathological point of view, the actual 
consequence is that myofibres become replaced by connective 
tissue and subsequently also by adipose tissue. In the mdx mouse, 
however, there is very little fatty acid replacement and endomysial 
or perimysial fibrosis (Bulfield et al, 1984; Coulton et al, 1988b). 
A characteristic fine-structural feature of prenecrotic fibres 
in DMD is the perforation or loss of the plasma membrane. A 
consequence of this early membrane abnormality seems to be the 
outward leakage of muscle fibre proteins such as creatine kinase 
and the inward movement followed by intracellular accumulation of 
calcium. Morphological support for this 'leaky membrane' 
hypothesis came from the observation that externally administered 
protein molecules (horseradish peroxidase) penetrate into the 
muscle fibres (Mokri and Engel, 1975; Engel et al, 1977). In the 
dystrophic mdx mouse, however, ultrastructural plasma membrane 
defects are quite uncommon (Hoffman et al, 1987). This latter 
observation in particular suggests that the differences between 
human DMD and mouse mdx dystrophy may be due to varying 
secundary pathological changes, consequent to the absence of the 
membrane associated protein dystrophin. 
It has once been stated that the debate on the relevance of 
animal models to human muscular dystrophies would end when 
specific biochemical defects were identified (Mendel et al, 1979). 
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The above brief elucidation concerning the differences between 
DMD and mdx dystrophy may indicate that this was too optimistic 
a view and also indicates that research on animal models other than 
the mdx mouse is needed to obtain more fundamental knowledge on 
the pathobiology of skeletal muscle dystrophy. It remains a primary 
goal to discriminate between primary and secundary events that 
lead to the specific pathology in the various muscular dystrophy 
conditions and to discover the causes of the various phenotypic 
disease expression. 
In our view, in particular the Bar Harbor ReJ 129 dy mouse 
strain warrants special attention because this model - although 
genetically different from DM/BM dystrophies - shows a series of 
clinical and histopathological similarities to DMD/BMD. For 
example, the onset of clinical symptoms is first recognizable at 
about two weeks of age, when homozygously affected animals 
show reduced locomotor activity, rapidly progressive weakness and 
start to drag their hind limbs. However, in DMD patients as well 
as in dy/dy mice, the skeletal muscle tissue shows signs of 
histopathological changes already before overt clinical signs appear 
(Platzer and Chase, 1964; Meier, 1967; Banker, 1968; Jaros and 
Jenkison, 1983; Wirtz et al, 1983). Whereas functional control of 
the hindlimbs is rapidly lost, affected animals attempt to move 
around using the atrophied forelimbs. Head nodding, muscular 
tremors and gasping respiration may occur in some of the affected 
animals, whereas kyphosis and contractures may supervene in the 
more advanced stages of the disease. The mice die when they are 
about five months old; healthy controls may reach ages up to two 
years. 
From the histopathological point of view the early 
appearance of wedge-shaped focal lesions at the periphery of large 
diameter muscle fibres is especially striking (Banker et al, 1979). 
These structural abnormalities are quite comparable to those 
described by Engel and co-workers in the muscle fibres of patients 
suffering from DMD (Engel et al, 1977). This finding in particular 
is suggestive for the existence of a membrane defect in this animal 
model, allowing efflux of myofibre proteins and influx of calcium 
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to induce focal myofibre hypercontraction attented with fatal 
cellular damage. 
As outlined above the aim of our studies was to obtain more 
information about possible the basic aspects of the pathobiology of 
the skeletal muscular dystrophy in the Bar Harbor ReJ 129 dy 
mouse strain. A number of recent studies give indications that in 
particular growth and differentiation / maturation of skeletal muscle 
fibres in this animal model is impaired. For example, Wirtz and 
coworkers (1983a; 1983b) compared postnatal growth and 
differentiation of muscle fibres of three hindleg muscles (soleus, 
plantaris, gastrocnemius) of normal and dystrophic mice using 
morphometric and histochemical procedures. The authors observed 
that during the course of the disease the percentage of 
'intermediate' fibres increased markedly, whereas nearly all 'fast-
glycolytic' fibres disappeared. Because of these shifts in fibre 
profiles, the authors conclude that the plantaris and gastrocnemius 
muscles in particular obtained a rather 'juvenile' (and 'oxidative') 
aspect. In dystrophic muscles, no new fibre types were found, 
compared with normal muscles. Rather, fibre types were present at 
the wrong moment, or occurred in quantities unusual for the age 
concerned. Dangain et al (1987) studied the histochemical 
developmental changes of succinate dehydrogenase (SDH) activity 
in individual fibres of normal and dystrophic muscles. It was found 
that, whereas in normal muscles the overall enzyme activity 
increases with the fibre population becoming heterogeneous, this 
increase is distinctly less in the dystrophic muscle where enzyme 
staining remains more or less homogeneous. Totsuka and 
coworkers (1981a) studied developmental changes of the hindlimbs 
muscle fibres in normal and dystrophic mice, biochemically by 
measuring age-related changes in the contents of phosphorus-
containing substances (DNA, RNA, phospholipid) and protein in 
whole muscle homogenates and histologically by studying 
frequency distributions of fibre diameters. Their results showed 
that, whereas in normal mouse apparent muscle cell volume 
increases dramatically during 2 weeks up to 2 months of age, cell 
volume remained almost constant during this period in the 
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dystrophic mouse. Based on a number of additional studies 
(Totsuka et al, 1981b; 1982; 1983) Totsuka and coworkers have 
subsequently put forward the so-called 'bone-muscle imbalance' 
hypothesis for the pathogenesis of the mouse dyldy muscular 
dystrophy. According to this hypothesis the early pathology is not 
degeneration but rather defective maturation (growth) of muscle 
fibres. Whereas the growth of bones is virtually normal, an age-
related aggravation in bone-muscle imbalance is considered 
responsible for the pathogenesis and progress of the disease. 
1.2 Contents of this thesis 
The question arises whether or not the differentiation and 
maturation of dystrophic muscles prior to the manisfestations of the 
symptoms of the disease is similar to that of normal muscles. 
Altered development and differentiation is possibly a secondary 
effect of the genetic defect and could be part of the mechanisms 
that lead from the genetic defect to the phenotypic expression of dy 
mouse muscular dystrophy. Because we are focussed in this thesis 
on maturation defects that possibly lead to the specific dy mouse 
pathology, we have concentrated on pre- and postnatal development 
and differentiation of skeletal muscle of dystrophic mice as 
compared to normal mice. The chronological expression of a 
number of muscle specific contractile and cytoskeletal proteins in 
pre- and postnatal stages of myofibre development were studied. 
In chapter 2 literature data on muscle fibre structure and 
normal muscle development and differentiation are briefly outlined. 
Attention is paid to the aspects of molecular determination of the 
myoblast cell type and factors that control the decision to establish 
the skeletal muscle phenotype. Considering the diversification of 
muscles and of specific myofibre types which form during 
myogenesis, brief attention was given to the item of myoblast 
diversity and its consequences through myoblasts fusion for 
myofibre fate. Recent information about the process of myoblast 
fusion and the development of multiple types of myofibres is also 
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briefly summarized. This chapter concludes with a literature 
overview on development and differentiation of the myofibril 
related to the expression of cytoskeletal proteins. 
Myosin isoforms represent sensitive markers of muscle fibre 
development and adaptation to physiological or pathological 
conditions. A detailed analysis of myosin isoform expression 
during the dystrophic process can therefore be of help in 
documenting possible effects of altered motor nerve discharge, in 
establishing different susceptibility of specific fibre types to the 
disease, and can elucidate possible interactions between 
degenerative and regenerative processes. A study on myosin 
isoforms is presented in chapter 3. 
Intermediate filaments (IF), which are known to be 
functional in the maintenance of the ordered organization of 
myofibres, have been shown to alter their composition and 
structural organization during maturation of myofibres. Indeed 
myofibre differentiation is accompanied by a profound 
redistribution of IF components, parallelled by a switch in gene 
expression. In normal myoblasts a major IF protein is vimentin, 
the expression of which is suppressed upon differentiation, while 
desmin expression is up regulated. Vimentin and desmin also form 
sensitive markers for myofibre degeneration and regeneration. In 
view of the ongoing discussion on the significance of the 
degeneration-regeneration process in the murine dystrophy 
(Totsuka and Uramoto, 1986; Totsuka, 1986; 1987) a study on the 
expression of desmin and vimentin during postnatal development of 
dystrophic as compared with normal mice was carried (chapter 4). 
Prenatal events of myotube formation and differentiation 
can be simulated by arranging a myosatellite cell culturing system, 
which give the opportunity to study the expression of a number of 
myogenic proteins during early development without extrinsic 
influences of neuronal and hormonal control. The expression of a 
number of cytoskeletal and contractile proteins in myoblasts and 
myotubes of normal and dystrophic murine muscle is analyzed in 
chapter 5. 
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As already mentioned above, the discovery of dystrophin as 
an associated component of the muscle normal fibre sarcolemma 
focussed renewed attention on the muscle fibre surface membrane 
as a key element in the pathology of muscular dystrophy. It seems 
obvious that absence of or a defect in a membrane-supporting 
protein will interfere with the mechanical strength of the myofibre 
membrane. In other words, an increase in mechanical load on the 
dystrophic muscle fibres will increase the chance of myofibre 
damage with risks of fibre degeneration and necrosis. 
In accordance with this is the observation that in dystrophic 
mice severe fibre necrosis occurs in particular during the second 
week postnatally when the animals start strolling around. 
Restriction of dynamic use of the hindlegs aimed at avoiding 
mechanical overload of the hindleg muscles during this vulnerable 
period (by procedures such as denervation, tenotomy or 
immobilization: Jaros and Johnstone, 1983; 1984; Loermans and 
Wirtz, 1983; Wirtz and Loermans, 1984) indeed largely prevents 
muscle fibre necrosis. Using the experimental protocol of hindleg 
immobilization as developed by Loermans and Wirtz (1983) we 
compared the functional capacity - by analyzing their isometric 
force characteristics - of dystrophic muscles with muscles that went 
through a period of early transient immobilization. The results of 
these studies are presented in the chapters 6 and 7 (section II). 
Our final remarks and conclusions are formulated in chapter 
8. 
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Normal muscle development 
and differentiation 

2. NORMAL MUSCLE DEVELOPMENT AND 
DIFFERENTIATION. 
2.1 Introduction 
The studies in part I of this thesis deal with aspects of 
differentiation and maturation of skeletal muscle in dystrophic mice 
as compared to healthy animals. A number of proteins important 
for muscle structure and function, with isoform expression 
dependent on the stage of muscle development and differentiation, 
are described in the following chapters. Ther now follows a basic 
outline of normal skeletal muscle structure and a brief elucidation 
of some of the events that take place during muscle development 
and differentiation. 
Skeletal muscle development or myogenesis starts with a 
population of committed mesenchymal, mononucleated cells, which 
exhibit prominent mitotic activity and accumulate at predetermined 
sites to form striated muscles. Using the nomenclature of Fischman 
(1986), these cells are called presumptive myoblasts, although they 
are morphologically identical to other mesenchymal cells. They 
become postmitotic, spindle-shaped, mononucleated cells termed 
myoblasts. Through fusion of myoblasts the myotubes are formed, 
which are multinucleated syncitia. It appears that at least in tissue 
culture fusion occurs mainly at the ends of the syncitium, resulting 
in a gradient of differentiation along the length of the myotube, 
with the most mature regions in the middle part of the syncitium. 
Knudsen and Horwitz (1977) recognized a sequence of distinct 
stages in the fusion process, i.e. first cellular recognition followed 
by cell adhesion and ultimately cell fusion. The myotubes are 
immature muscle fibres in which the myofibrils are 
circumferentially distributed around a central core of nuclei. The 
myotubes are called myofibres when the nuclei have migrated to 
the periphery and occupy a subsarcolemmal position while the 
myofibrils attain a more orderly organized distribution in the 
myoplasm. Each myofibril consists of a chain of sarcomeres, 
which can be considered to be the contractile units. The precise 
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organization of the myofibrils in the myofibres is maintained by a 
variety of cytoskeletal proteins. The major protein components of 
vertebrate skeletal myofibres are given in table I. The vertebrate 
striated myofibril also contains a number of other proteins not 
included in this table (modified after Alberts et al, 1989). 
TABLE I: Major protein components of vertebrate skeletal myofibres 
Protein MW (kDal) Localization and function 
Myosin 510 Major component of thick filaments. Interacts with actin filaments 
under hydrolysis of ATP to develop mechanical force. 
Actin 42 Major component of muscle thin filaments; thick filaments slide 
alongside these thin filaments during muscle contraction. 
Tropomyosin 64 Rodlike protein that binds along the length of an actin filament. 
Troponin 87 Complex of three polypeptides (TnC, Tnl, TnT) positioned at 
regular intervals along actin filaments and involved (TnC) in the 
Ca2* regulation of muscle contraction. 
Titin = 2S00 Very large flexible protein that forms an elastic network linking 
thick filaments to Z-discs. 
Nebulin 600 Elongated, inextensible protein attached to Z-disc, oriented parallel 
to actin filaments. 
Vimentin 52-58 Widely distributed in cells of mesenchymal origin. Often expressed 
by cells in culture and thought to bind indirectly to the plasma 
membrane. 
Desmin 50 Provides mechanical support for the sarcomeres and ties the edges 
of the Z-discs together. 
a-actinin 190 Actin-bundling protein that links actin filaments together at the 
level of the Z-disc. 
Myomesin 185 Myosin-binding protein present at the central M-line of the muscle 
thick filament. 
Dystrophin 400 Very large protein, associated with the cytoplasmic side of the 
sarcolemma and presumably anchoring elements of the internal 
cytoskeleton to the surface membrane. 
C-protein 140 Myosin-binding protein found in distinct stripes on either side of 
the thick-filament M-line. 
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2.2 Structure of the myofibre 
2.2.1 Contractile proteins 
The contractile units or sarcomeres of each myofibril are 
composed of thick (Α-filament) and thin (I-filament) filaments and 
Z-disc structures (fig 1). 
Figure 1 : Organization of the sarcomere. 
Electron micrograph of striated muscle showing some sarcomeres in 
longitudmal section: on either side of the Z-disc are the light-staining 
I bands, composed of thin filaments. These extend from the Z-disc 
and interdigitate with the dark-stained thick filaments that make up 
the A band. The region containing both thick and thin filaments is 
darker than the area containing only thick filaments (H-zone). 
The major protein of the thin filament is actin. Actin is a 
highly abundant protein in many eucaryotic cells. A number of 
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actin isoforms, tissue and/or developmental stage specific, are 
described by several authors; for a review see Buckingham and 
Minty, 1983. Presumptive myoblasts contain 0 and τ isoforms of 
actin (Garrels and Gibson, 1978; Shimizu and Obinata, 1980). 
These actin filaments may be important in myoblast movement, 
Chemotaxis and cell-cell recognition. In the myotube, the actin 
filaments, also called filamentous actin or F-actin, are composed of 
globular subunits. Each subunit is composed of a single 
polypeptide, known as globular actin or G-actin, and is associated 
with one molecule of non-covalently bound ATP. Polymerization 
of the subunits into F-actin occurs under hydrolysis of ATP. The 
subunits are packed into a tight helix with about two monomers per 
turn. This may give the misleading appearance of two helical 
strands twisting around each other (fig 2). Actin filaments are polar 
structures, with two structurally opposing ends. Other proteins 
associated with the thin filament are tropomyosin and troponin, 
which form about one third of its mass. Tropomyosin forms a two-
stranded α-helix rod, lying in the grooves of the thin filament. 
Troponin is a complex of three polypeptide chains, troponin-T 
(TnT; tropomyosin-binding), troponin-I (Tnl; Inhibitory) and 
troponin-C (TnC; calcium-binding). The tail of TnT is bound to 
tropomyosin and is thought to be responsible for positioning the 
complex on the thin filament. Tnl binds to actin and, added to 
troponin Τ and tropomyosin, it inhibits interaction of actin and 
myosin. TnC binds Ca++ and is closely related to calmodulin, 
which mediates Ca++-signaled responses in all cells. TnC may 
therefore be regarded as a specialised form of calmodulin. It has 
permanent binding sites for both Tnl and TnT. Ebashi and 
coworkers (see review, 1973) discovered that the effect of Са++ on 
the interaction of actin and myosin is mediated by tropomyosin and 
the troponin complex and that tropomyosin sterically blocks the 
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Figure 2: Schematic drawing of the muscle thin fílament showmg the position 
of tropomyosin and the troponin complex alongside the actin 
filament (adapted from Alberts et al, 1989). 
The major protein of the thick filaments in skeletal 
muscle is myosin. Each molecule consists of six polypeptide 
chains: two identical heavy chains and two pairs of light chains (fig 
3a). Electron microscopy reveals two parts in the molecule: a tail 
part called the myosin rod or myosin tail, responsible for the 
spontaneous assembly of the myosin molecules into the thick 
filaments, and two globular heads, also called subfragment-1 (Si-
fragment), which are responsible for the interaction with the thin 
filament. The rigid structure of the myosin tails is a "coiled coil", 
i.e. two α-helices with a characteristic spacing of hydrophobic 
residues that coil around each other. In the myosin filament the 
tails of the individual myosin molecules associate to form the thick 
filaments, while the heads are projected to the outside of the 
filament (fig 3b). 
In vitro purified myosin assembles into synthetic thick 
filaments, which are heterogeneous in length (Whiting et al, 1989). 
In muscle cells in vivo, however, these interactions are stabilized 
by various proteins. Whiting et al (1989) proposed that the length 
of the myosin filaments is controlled by the cytoskeletal protein 
ti tin (see 2.2.2). An accessory protein associated with the thick 
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Light chain 1 Light chain 2 
(LC-1) (LC-2) 
b Heads Tail 
Figure 3: Diagram of (a) myosin molecule, which consists of two pairs of two 
different light chains (LC-1, LC-2) and two identical heavy chains. 
(b) Model of a bipolar myosin thick filament. The central zone is 
composed only of packed tails without heads (adapted from Darnell 
et al, 1990). 
filament is C-protein. It consists of a single polypeptide chain, that 
binds to myosin and is found in distinct stripes on either side of the 
thick-filament midline (M-line) (Offer, 1973). 
2.2.2 Structural proteins 
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More than a dozen proteins have been identified so far, 
which have a function in the maintenance of the precisely ordered 
structure of the myofibre (Table I) and this list of proteins is still 
growing. 
The intermediate filament protein (IFP) desmin, formerly 
called skeletin, was identified by Lazarides and Hubbard (1976). 
Desmin has subsequently been identified as a component of avian 
and mammalian smooth, skeletal and cardiac muscle (reviewed by 
Lazarides, 1982). In skeletal muscle desmin appears to be 
associated with the lateral edges of the sarcomeres, predominantly 
at the Z-band level (Lazarides, 1978; Bennett et al, 1979; Gard and 
Lazarides, 1980), where it forms a transverse network encircling 
and interlinking adjacent Z-discs (Granger and Lazarides, 1978) 
(fig 4). This explains why desmin appeares in a cross-striated 
pattern in longitudinal sections of skeletal muscles. At the site of 
the Z-disc desmin is codistributed with the proteins synemin 
(Granger and Lazarides, 1980) and filamin (Gomer and Lazarides, 
1981). Filamin is present in two different isoforms separately 
found in two distinctive developmental stages of myogenesis. One 
is associated with microfilament bundles in myoblasts and young 
(immature) myotubes, the second form with the Z-band scaffold of 
mature myofibrils (Gomer and Lazarides, 1983). 
A protein present in all vertebrate skeletal muscle that 
functions as a longitudinal elastic element and accounts for passive 
tension, was first isolated by Maruyama and et al (1976). The 
protein was named connectin. Independently, Wang et al (1979) 
isolated a protein, which they called titin, with properties identical 
to connectin. By SDS-gel electrophoresis and immunofluorescence 
studies it was confirmed that connectin and titin were on and the 
same protein (Maruyama et al, 1981). Horowits et al (1986) 
showed that titin filaments serve as a filament system to provide an 
elastic network for the myofibril. In the mature myofibril, titin 
molecules span from M-line to Z-line and link the thick filaments 
with the Z-discs (fig. 5). Horowits and Podolsky (1987) also 
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Figure 4: A model of Z-band linkage to the sarcolemma, shows the localization 
of the IF desmin and vimentin m the myotibre (adapted after 
Fischman, 1986). 
showed that the elastic titin filaments act to resist the movement of 
thick filaments away from the M-line of the sarcomere during 
stretching. Whiting et al (1989), using a series of monoclonal 
antibodies each recognizing titin epitopes, studied the subcellular 
localization of this protein. Their data indicate that individual 
molecules extend from near the M-line to beyond the end of the 
thick filament. In the Α-band titin appeares to be associated with 
the thick filament, probably to the outside of the filament shaft. 
These authors suggest that the appearent specific topological 
distribution of titin makes it a likely candidate as a regulator of 
thick filament length during filament assembly. 
Another protein of skeletal muscle is nebulin. Nebulin is 
a large, abundant protein which forms long filaments spanning 
from the Z-line to the distal end of the thin filaments. It has been 
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speculated that nebulin acts as a template protein which interacts 
with actin and may determine thin filament length (Wang and 
Wright, 1988; Jin and Wang, 1991). Immunoelectron microscopy 
of skinned muscle fibres and immunofluorescence studies revealed 
that nebulin constitutes of a set of long inelastic parallel filaments 
that are not serially connected with the elastic titin filaments (Wang 
and Wright, 1988). In a model concerning the architectural 
organization of the sarcomere they distinguish four filament types, 
the contractile filaments myosin and actin, and the cytoskeletal 
filaments titin and nebulin, which are directly (actin, titin, nebulin) 
or indirectly (myosin via titin) linked to the Z-line (fig 5). 
A protein important in the ordered organization of the 
thin filaments in the sarcomere is a-actinin; first described by 
Ebashi and Ebashi, 1965. This protein is a dimer of two identical 
polypeptides. a-Actinin cross-links actin polymers at the level of 
the Z-disc and bundles them into the characteristic hexagonal 
lattice. a-Actinin amounts to about 50% of the mass of the Z-disc. 
A protein functionally similar to a-actinin is myomesin, which 
cross-links adjacent myosin filaments at the M-line in a hexagonal 
bundles. 
A protein which shares many features with a-actinin, first 
discoved by Hoffman and coworkers (1987), is dystrophin. 
Watkins et al (1988) showed that dystrophin is a sarcolemma-
associated protein localized at the cytoplasmic side. It was shown 
by Campbell and Kahl (1989) that an integral membrane 
glycoprotein in the sarcolemma is a dystrophin-receptor, which 
anchors dystrophin to the membrane. It has been proposed that 
dystrophin provides mechanical strength for the sarcolemma and in 
this way protects the skeletal muscle membrane against the stresses 
associated with contraction and stretching (Zubrzycka et al, 1988) 
(see also chapter 8). 
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Actin thin Myosin thick 
filament filament 
Ζ disk 
A hypothetical four-filament model of the architectural organization 
of the myosin, actin, titin and nebulin filaments in the sarcomere. 
The elastic titin filaments link myosin thick filaments to the Z-discs 
and keep them centered in the sarcomere when the muscle is 
stretched. Nebulin forms inextensible filaments, anchored at the Z-
discs, which may act as organizing elements for the actin filaments 
(adapted from Darnell et al, 1990). 
2.3 Mvogenesis 
2.3.1 Molecular determination of the myoblast cell type 
Early in embryogenesis totipotent stem cells give rise to 
multipotent mesodermal stem cells, from which myoblasts are 
derived. As indicated in the previous section, the mature skeletal 
muscle cell is characterized by the presence of a large number of 
specific proteins involved in muscular contraction, muscle fibre 
metabolism and excitation-contraction coupling. In proliferating 
myoblasts, these muscle specific proteins are either absent or 
present in very low levels. However, at the induction of myoblast 
fusion, the expression of these proteins strongly increases. 
Insight into the molecular mechanisms that control the 
establishment of this skeletal muscle phenotype has been gained 
since the discovery that the entire series of specific muscular 
differentiation events - including cell fusion - can be triggered in 
cultured fibroblasts. The genesis of the skeletal muscle phenotype 
is possibly controlled by a set of myogenic genes that co-ordinate 
subsequent myoblast differentiation. The first regulatory gene 
characterized was MyoD-1 (Davis et al, 1987). It was shown that 
the full length MyoD-1 cDNA transfected into СЗНЮТУг 
fibroblasts converted them to stable myoblasts. Shortly thereafter, 
Pinney et al (1988) demonstrated that another gene, Myd, 
converted 10T!/2cells to the myoblast lineage and concluded that 
there is a simple genetic basis for myogenic determination. More 
recently, a factor designated myogenin was also found to activate 
the muscle differentiation program (Wright et al, 1989; Edmondson 
et al, 1989). Subsequently, MyF-5 (Braun et al, 1989), MRF4 
(Rhodes and Konieczny, 1989) herculin (Miner and Wold, 1990), 
MEF-2 (Gossett et al, 1989) and MCBF (Mar & Ordahl, 1990) 
have been added to the family of skeletal muscle-specific gene 
products that can convert non-muscle cells to the myogenic lineage. 
Recent evidence indicates that although not all of these genes are 
essential for expression of the myogenic program (Olson et al, 
1991), myogenin is potentially a controller of terminal 
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differentiation in both rat and mouse muscle lines since this protein 
is expressed in every cell undergoing myogenic differentiation. In 
addition, myogenin also induces non-muscle cells to express muscle 
specific genes. 
It is considered beyond the scope of this introductory 
chapter to give an extensive overview of the recent literature on the 
molecular control of myogenesis. The reader is referred to some 
recent reviews concerning this active field of developmental 
biology research, as well as to the original literature cited in these 
reviews (Davis et al, 1987; Pinney et al, 1988; Tapscott et al, 
1988; Murre et al, 1989a; 1989b; Davis et al, 1990; Oison et al, 
1991). Here we confine ourselves to a brief description of the 
significance of hormones and growth factors in the regulation of 
myogenic differentiation, and of the existing evidence for myoblast 
diversity in skeletal myogenesis. 
2.3.2 Control of the myogenic differentiation 
Although myoblasts are committed to myogenic 
differentiation, cultured myoblast may either remain in their 
undifferentiated proliferating state or may enter the postmitotic 
differentiation pathway. Until recently, it was generally considered 
that medium components played the primary role in controlling 
myoblast differentiation in vitro, since fresh serum-rich medium 
blocked differentiation, and serum-poor 'conditioned' medium that 
has been incubated with cells for some days, allowed 
differentiation to occur. Consequently, it was generally believed 
that the metabolic degradation of mitogens in the latter medium 
was responsible for the more rapid differentiation that occurred, 
although the possibility that mitogenic inhibitors might be present 
in serum or chick embryo extract was apparently not considered. 
The proper evaluation of the role of mitogens was 
hampered by the fact that specific agents were not available in pure 
form and in sufficient quantities. More recently, however, 
recombinant growth factors have become commercially available, 
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and it is now possible to develop well-defined culturing systems. 
Consequently, it has been established that the terminal 
differentiation of muscle cells in culture is subject to control by 
growth factors and classical peptide hormones in the medium 
(Florini and Magri, 1989). Apparently, differentiation is controlled 
through a repression type mechanism in which mitogens in serum 
or specific growth factors block the expression of muscle specific 
genes (Spizz et al, 1986; Olson et al, 1986). Depletion of growth 
factors below a critical level result in the activation of the 
differentiation program. Thus far, the most extensively studied 
agents involved in regulating growth and differentiation of muscle 
cells are fibroblast growth factor (FGF), the insulin-like growth 
factors (IGF's) and transforming growth factor-ß (TGF-ß). All 
three of these agents exert major effects on the differentiation of 
skeletal muscle cells. FGF and TGF-ß are potent inhibitors of 
myogenic differentiation whereas the IGF's exhibit a stimulatory 
action. Significantly, all these growth factors/hormones affect the 
expression of the myogenin gene. In addition, TGF-ß and FGF 
have been shown to inhibit the expression of MyoDl, and possibly 
both myf-5 and herculin (Florini et al, 1991). Although these 
agents can either inhibit or stimulate all measured aspects of 
myogenic differentiation, further studies on their effects on both 
myoblast and primary muscle cell cultures remains necessary. 
A number of excellent reviews (Florini and Magri, 1989; 
Olson et al, 1991; Florini et al, 1991) summarize the results 
recently achieved in this flourishing field of developmental biology 
research. The reader is referred to these papers for additional 
information. 
2.3.3 Myoblast diversity 
In the vertebrate body dozens of individual muscles, 
composed of diverse types of myofibres with varying physiological 
functions and biochemical capacities are formed during 
myogenesis. An interesting problem is, therefore, which cellular 
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mechanisms underlie this formation and diversification of muscles 
and muscle fibres. Of particular importance is the question which 
aspects of myogenesis are intrinsic to myogenic cells and which 
aspects depend on the interaction with other cell types. 
Because it is known that under the influence of motor 
neuron activity the characteristics of adult and neonatal myofibres 
can change, it has long been assumed that embryonic muscle fibres 
are all intrinsically alike and that diversification arises under the 
influences of extrinsic, in particular, neural control. However, 
there is now convincing experimental evidence to indicate that -
whereas later foetal and postnatal stages of myogenesis are 
profoundly impaired when innervation is disturbed - early 
embryonic fibre formation and diversification is largely 
independent of innervation. Important indications came from the 
studies of Miller and Stockdale (1986) who showed that the limbs 
of chicken embryos are physically denervated or paralysed with 
curare at stages prior to the arrival of motor neurons in the limb, 
neither initial muscle formation nor formation of primary fibres of 
differing types, is affected. To confirm their idea that these early 
processes of muscle development in birds are nerve-independent, 
Miller and Stockdale (1987) analysed the myosin heavy chain 
(MHC) profiles of myotubes formed from cloned embryonic and 
foetal myoblasts in vitro. They prepared clonal cell cultures 
derived from individual embryonal myoblasts wherein all myotubes 
were formed from the progeny of a single ancestral cell. They 
found that three different types of muscle colonies were formed 
from the embryonic myoblasts, with every colony being composed 
of one type of myotube only. From their results, they concluded 
that embryonic myoblasts are indeed a heterogeneous population. 
Also Hoh and Hughes (1991) demonstrated by in vivo 
transplantation experiments in cat that different types of myofibres 
are formed from different myoblasts. They transplanted strips of 
jaw muscles, which are composed of superfast MHC myofibres, 
bilaterally in the beds of a fast limb muscle and allowed 
regeneration to occur, however with innervation on one side 
prevented surgically. Their results showed little difference between 
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the innervated and non-innervated muscles that had regenerated up 
to 27 days postoperatively. All the regenerating myotubes 
expressed foetal myosin. In addition, some myotubes 
immunostained for superfast or slow myosin, while others stained 
for both superfast and slow myosins. Uninnervated myotubes 
became atrophic but continued to express foetal slow and superfast 
myosins, while innervated myofibres suppressed expression of 
foetal and slow myosin. From these results it can be concluded that 
there must be multiple types of myoblasts (and satellite cells), 
committed to form myotubes with diverse morphologies and MHC 
phenotypes, even in the absence of innervation. 
Myogenesis begins when cells in the embryonic somites 
that acquire myogenic potential and migrate to the muscle-forming 
regions of the limbs and the trunk. After a proliferative period, 
these myoblasts withdraw from the cell cycle and fuse to form 
multinucleated muscle fibres. According to Miller (1992), there is 
a first stage of myogenesis in embryonic limbs in which primary 
muscle fibres are formed before morphogenesis is complete. As 
foetal development continues, secondary muscle fibres are formed 
parallel to a primary fibre, which suggests the existence of distinct 
lineages of myoblasts. According to the model presented by Miller, 
there are three types of myoblast: embryonic, foetal and satellite 
cell myoblasts. Embryonic myoblasts are destined to initiate the 
formation of primary myotubes. Each type of primary myotube 
would be independently formed by a different type of embryonic 
myoblast. The foetal myoblasts would then be generated and used 
to initiate the formation of secondary myotubes. Postnatal growth 
of myofibres would be achieved by fusion of primary and 
secondary fibres with satellite cell myoblasts that begin to appear 
late in foetal development and replace the earlier myoblast types 
after birth. Consequently, embryonic and foetal myogenesis in all 
likelyhood proceed by mechanisms different from those that prevail 
during postnatal myogenesis. 
It is known that clones of myoblasts analyzed in vitro 
express fast and slow myosin isoforms typical of the muscle from 
which they are derived, and it has been suggested that distinct 
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myoblast lineages generate and maintain muscle fibre pattern. 
Hughes and Blau (1992) investigated whether selective fusion of 
myoblast lineages plays a role in maintaining muscle fibre growth 
and development. Using a retrovirus to label myoblasts genetically 
so that the fate of individual clones could be monitored, they found 
that myoblast clones labeled in muscle in situ as well as clones 
labeled in muscle culture and then injected into various muscles 
contribute to all fibre types encountered. These results 
demonstrated that in postnatal development, MHC pattern is not 
dictated by myoblast lineage. 
To illustrate this point somewhat further, recent work 
raises the idea that myoblasts carry positional identity. In a study 
to identify intermuscular differences in gene expression that might 
correlate with synaptic difference, Sanes and coworkers (1991) 
sought to identify variations in transgene expression among 
muscles of transgenic mice. A very striking finding was a more 
than 100 fold rostrocaudal gradient of chloramphenicol 
acetyl transferase (CAT) levels in muscles of adult mice that bear a 
myosin light chain lf/3f (MLCl)-CAT transgene. Donoghue and 
coworkers (1992) extended these results and established cultures 
derived from muscles of adult MLCl-CAT mice to analyse if the 
positional gradient of gene expression is retained in culture. Their 
results showed that cultures derived from myoblasts isolated from 
individual adult muscles express CAT levels characteristic of their 
rostro-caudal position of origin, indicating that intermuscular 
differences are not dependent on innervation, electrical activity or 
extramuscular gradients. In addition position-dependent expression 
of CAT was also shown in embryos and in cultures prepared from 
embryos, demonstrating that intermuscular differences appear and 
become stable before birth. Also in cell lines derived from 
individual adult myogenic satellite cells, intermuscular differences 
in CAT levels are maintained, indicating that the positional 
memory is cell autonomous and heritable. 
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2.3.4 Fusion of myoblasts 
Although membrane fusion is a basic biological 
phenomenon, cellular membranes do not fuse spontaneously. In 
order to fuse, the interacting lipid layers have to approach within 
0.5 nm of each other. This requires water to be displaced, a 
process that is highly unfavourable from an energetic point of 
view. Fusion of cells, after selective mutual recognition, is an even 
more complex phenomenon, involving a wide range of biophysical 
and biochemical interactions. Accordingly, cell fusion is a very 
rare event, and under non-pathological conditions occurs only 
between sperm and egg during fertilization and between myoblasts 
in the formation of multinucleated skeletal muscle cells. Fusing 
myoblasts undergo a dramatic switch of phenotype dependent on 
the coordinated activation of muscle specific genes (see above). 
Once fusion between myoblasts has occurred, the nuclei never 
replicate their DNA. Myoblast fusion is the result of specific 
processes of cell recognition and adherence (Wakelam, 1985). 
A study of Knudson and Horwitz (1977) with chicken 
embryonic breast muscle cells have indicated that the process of 
myoblast fusion consists of a sequence of two distinct initial stages: 
cellular recognition followed by cell adhesion. During the first 
phase, which is of limited duration, myoblast aggregates can be 
dispersed by treatment with EDTA, i.e. by removal of calcium-
ions. This initial phase appears to be sensitive not only to the 
concentration of Ca++ in the culture medium, but is also dependent 
on pH, temperature and age of the myoblast culture. 
Thereafter, the myoblast aggregates become resistant to 
dispersion by EDTA, but can still be dissociated by treatment with 
trypsin. This second phase is also of limited duration and the next 
stage of irreversible myoblast adhesion is presumed to reflect the 
onset of membrane fusion (Neff et al, 1984). Interestingly, 
myoblasts which have arrived at the stage of irreversible adhesion, 
ultrastructurally show close membrane apposition similar to gap 
junctions, and can be shown to be electrically coupled by electro-
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physiological techniques (Rash and Fambrough, 1972; Rash and 
Staehelin, 1974). 
Although myoblast fusion is Ca++ myoblasts can, 
however, divide, align and achieve fusion competence when 
cultured in medium with Ca+^concentrations as low as 0.1 μΐη 
(Wakelam, 1985). The addition of calcium ions to such cells 
results in rapid fusion and it has been shown that the optimum 
Ca++ concentration for fusion is 1.4 mM (Van der Bosch et al, 
1972; Schudt and Pelli, 1975) 
As can be readily observed in primary cultures of 
embryonic myoblasts or satellite cells, fusion occurs following the 
process of alignment. Alignment is the parallel apposition of the 
long axis of the myoblasts. The molecular factors that actually 
specify myoblast alignment are largely unknown, but there are 
indications that myogenic cells are guided by fibronectin. 
Fibronectin is an extracellular adhesive glycoprotein involved in 
cell attachment to the extracellular matrix, in the regulation of cell 
shape and the promotion of cell adhesion and the guidance of cell 
migration (Kleinman et al, 1981; Yamada (1983). It has recently 
been suggested that fibronectin contains a "matrix assembly site" 
for its binding to a "matrix assembly receptor" on substrate-
attached cells, and a "cell adhesion site" for a "cell adhesion 
receptor" on suspended cells (McKeown-Longo and Moshes, 
1985). Moreover, matrix assembly sites may be either inactive or 
rapidly down regulated in suspended cells, but re-expressed during 
or after cell spreading (McDonald, 1988). 
Walsh and Phillips (1981), using several surface labelling 
methods, noticed that levels of fibronectin at the myoblast cell 
surface increase during the process of cell fusion and decline 
during further myotube differentiation. Immunocytochemical 
studies (Walsh and Phillips, 1981; Kang et al, 1983; 1985) also 
showed that as myoblast fuse, the association with fibronectin at 
the cell surface is lost. The evidence therefore suggests that the 
loss of fibronectin from the surface of myoblasts is important in 
the regulation of myoblast fusion and that its continued presence is 
inhibitory to myogenesis. As has been pointed out by Chung and 
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Kang (1990), however, the precise mode of changes in the 
fibronectin levels during myogenesis is as yet unknown. 
Glycoproteins are thought to be involved in the process since 
tunicamycin, an inhibitor of protein glycosylation, has been shown 
to inhibit myoblast fusion (Gilfix and Sanwal, 1980). However, the 
addition of exogenous fibronectin relieves the inhibition of fusion 
in tunicamycin-treated myoblast cultures (Chung and Kang, 1987), 
and the possibility therefore exists that the disappearace of 
fibronectin from the surface of fusing myoblasts may not be due to 
changes in the rate of fibronectin synthesis (Gardner and 
Fambrough, 1983). Chung and Kang (1990) therefore approached 
the problem not only by measuring fibronectin levels during 
myoblast differentiation but also by attempting to identify the 
receptor for fibronectin in the myoblasts and to examine the 
changes in receptor levels during myogenesis. Their results suggest 
that the loss of fibronectin during fusion is closely correlated with 
the loss of fibronectin receptors. This clearance of fibronectin from 
the myoblast cell surface may provide a permissive environment 
for myoblast fusion to occur. 
2.3.5 Muscle fibre diversity 
The diverse types of myofibre are characterized by the 
products of different gene families that contribute to generate the 
contractile apparatus. Myosin heavy chains (MHC) have been 
intensively studied in this regard because the MHC type is closely 
correlated with the velocity of myofibre contraction and the 
ATPase activity of the constituent MHC. Whalen et al (1981) 
demonstrated the existence of three major categories of MHC 
isoforms, and because these isoforms are expressed at established 
developmental stages they were designated "embryonic", 
"neonatal" and "adult". However, they are not necessarily unique 
to each of these stages (Crow and Stockdale, 1986). As 
development progresses distinctively "adult" MHC isoforms 
(MHCsl(W and MHCfllst types) appear in different populations of 
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myofibres, giving rise to the "mosaic" pattern characteristic of 
most adult vertebrate muscles. 
Skeletal muscle fibres are formed by temporally discrete 
rounds of myoblast fusion (Schmalbruch, 1985). At least two 
rounds of myoblast fusion can be detected in limbs of birds and 
rodents, which give rise to primary and secondary myotubes 
respectively, while in humans a third round of fusion gives rise to 
tertiary myotubes (Draeger et al, 1987). With regard to the 
expression of MHC isoforms a marked difference between primary 
and secondary myotubes can be observed. Figure 6 gives a 
simplified scheme showing lineage of myotube fate during 
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Figure 6: Lineage of myotube fate during development based on the expression 
of MHC isoforms in the rat hindlimbs (taken from Gunning and 
Hardeman, 1991) 
In both primary and secondary myotubes the first MHC 
gene expressed encodes the developmental isoform MHCo,,,,, which 
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is not expressed in adult muscle. Subsequently, ΜΙΚ^, and 
МНС,,,.«, are also expressed, together with МНС^ь in all primary 
myotubes except in those of the soleus muscle. Thereafter, for all 
but the soleus muscle, a first decision is made between the 
expression of either MHC
neo
 or MHC
sIOW isoforms, which in turn 
preceeds the final commitment to differentiate into either a slow or 
fast myofibre. In contrast, secondary myotubes first express both 
MHC
neo
 and MHCnnb before an eventual decision to express 
MHC
slow, which determines the differentiation fate of the myofibre. 
The decision to express either MHC,,^ or MHC,,^ isoform may 
therefore be considered to be crucial in determining fibre fate. 
Whalen (1985) considered the MHC embryonic and neonatal 
isoforms to be the precursors for the fast myofibre types. This may 
be a reflection of chromosomal linkage of the MHC ,^,,
 m0i adult faat 
genes in contrast to MHC9,0W, which is located on a separate 
chromosome. This organization of genes may reflect the order in 
which they are expressed. The final selection of adult MHCfast 
isoforms in a specific fibre is much more complex. 
A scheme of the multiple regulatory mechanisms 
summarizing the existing data of studies of the chicken, rat and 
mouse that may regulate MHC isoform expression in developing 
and regenerating myotubes is given by Gunning and Hardeman 
(1991) (fig 7). In this scheme nerve dependent and nerve 
independent influences are distinguished. In primary myotubes, the 
expression of MHC^,, and MHC
sl0W is intrinsic, while MHCneo is 
determined by separate environmental influences. The maintenance 
of MHC
sl(W expression is nerve dependent once it is initiated, while 
MHC,,«, and MHCfasl isoforms are expressed in the absence of 
neural input. In secondary myotubes МНС^ь expression is shown 
to be intrinsic, while MHC
neo
 is environmentally controlled. Nerve 
dependent is the initiation of MHC
slow expression. Satellite cells 
involved in muscle regeneration resemble secondary myoblasts, 
thus expressing MHC,^, while neural input is required to select 
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Figure 7: Multiple regulatory mechanisms that may regulate MHC isoform 
expression in developing and regenerating myotubes (taken from 
Gunning and Hardeman, 1991). 
As myotubes mature, they appear to respond to extrinsic 
factors, such as changes in activation pattern or hormone levels. 
Modulation of MHC isoform expression may thus occur, with 
different MHC isoforms being expressed within an individual 
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myotube at different stages of development. Experiments of a 
number of authors (see review: Pette and Vrbova, 1985) strongly 
indicate that innervation can play a pivotal role in the 
determination of muscle fibre type. Classic studies of Duller et al 
(1960) demonstrated that changes in firing patterns can transform a 
fast-twitch muscle into a slow-twitch one or visa versa. Muscle 
regeneration has also been used as an experimental system to 
examine the role of innervation in determining muscle fibre type. 
Comparison of regenerating muscles in the presence or absence of 
innervation has provided a discrimination between the 
responsiveness of fast and slow MHC isoforms (Whalen et al, 
1990; Cemy et al, 1987). The results of these studies argue that 
nerves may influence the ability to express MHC
sl0W and complete 
the MHCneo to MHC,dult Гля1 transition (Gunning and Hardeman, 
1991). 
The effects of hormones on the differentiation of muscle 
fibre have been the subject of intensive studies (reviewed by 
Florini, 1987). However, only thyroid hormone has been shown to 
influence fibre type differentiation by affecting the rate of 
maturation. Izumo et al (1986) investigated the effects of thyroid 
hormone concentration on the expression of the MHC multigene 
family by analysing the expression of six different MHC genes in 
seven different muscles of adult rats subjected to hypo- or 
hyperthyroidism. Their results demonstrated that all six genes were 
responsive to thyroid hormone, but the same MHC gene can 
respond quite differently within different muscles. 
During the determination of the adult fibre types, 
environmental influences act late in the development of the skeletal 
muscles to coordinate contractile protein gene expression. In a 
study of the transciptional regulation of 21 genes encoding different 
contractile protein isoforms (including MHC, MLC, tropomyosin, 
troponin C, I and T) during hindlimb development in the rat and in 
man, it was found that there is no fast or slow program of 
coordinated gene expression during early myogenesis (Sutherland et 
al, 1991). However, in the later stages of myogenesis there is a 
significant increase in mRNA output from the fast isoform gene of 
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each contractile protein gene family which leads to a coordinated 
"fast" phenotype. Their results do not support preprogrammed 
expression of fast or slow contractile proteins en masse in the 
differentiating myoblast. 
2.3.6 Myofibrillogenesis 
Cardiac and skeletal muscle are unique in possessing 
sarcomeres, highly ordered and periodic arrays of thick and thin 
filaments, which generate the contractile force of muscle. Normal 
functioning of muscle is dependent on the strictly defined 
organization of the sarcomeres and, as mentioned in paragraph 2.2, 
a number of proteins form part of the structural organization. It is 
obvious that during myofibrillogenesis, the ordering of different 
sets of proteins must occur very precisely and in an ordered 
sequence. 
At the early stages of myogenesis, i.e. when myogenic 
cells withdraw from the cell cycle, myoblasts are already capable 
of synthesizing and accumulating muscle-specific proteins (Hill et 
al, 1986; Colley et al, 1990). After myoblasts fuse to produce 
myotubes, these proteins become more prevalent. The expression 
of the intermediate filament proteins (IFP) vimentin and desmin 
were among the first to be identified as being influenced during 
differentiation. Desmin was initially regarded to play an important 
role in the organization of the sarcomeres, while vimentin appeared 
to be present in cells of mesenchymal origin and is readily 
observed in replicating presumptive myoblasts in the early stages of 
development when desmin is undetectable (Fischman, 1986). 
Desmin synthesis is initiated when a replicating presumptive 
myoblast becomes a postmitotic myoblast. Initially, coexpression of 
vimentin and desmin, detected as dispersed single filaments or 
filament bundles, is seen during early myogenesis (Bennett et al, 
1978). Later on the expression of desmin becomes more 
prominent, while vimentin expression is down regulated (Bennett et 
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al, 1979; Gard and Lazarides, 1980). Ultimately vimentin is lost 
from the myotubes (Fürst et al, 1989). 
More recently the myofibrillar proteins titin and nebulin 
were discovered (Maruyama et al, 1976; Wang and Ramirez-
Mitchell, 1980). These proteins probably play a role in regulating 
the thick and the thin filament length respectivily. The 
identification of titin has sharpened interest in the function of this 
protein and stimulated a resurgence in the study of the 
development, structure and organization of the sarcomere. Several 
in vivo and in vitro studies have been performed to elucidate the 
spatial and temporal aspects of expression of the specific 
myofibrillar and intermediate filament proteins during development 
of heart and skeletal muscle in several species. The first muscle 
specific protein to be expressed during myogenesis has been a 
subject of some disagreement. Fürst et al (1989) studied the onset 
of expression of different myogenic proteins during myogenesis in 
the mouse embryo. They showed that the expression starts in the 
cervical somites and reported the initiation of desmin in replicating 
presumptive myoblasts, which still contain vimentin, as the first 
recognizable step in myogenesis. They conclude that in the mouse 
the order of the onset of expression is desmin, titin, muscle 
specific actin and myosin heavy chains, and nebulin. 
In contrast, Schaart and coworkers (1989) demonstrated 
the presence of titin in the early heart anläge before desmin 
expression and an almost simultaneous appearance of titin and 
desmin in nascent myotome cells. From these results they 
concluded that titin is one of the earliest markers for cells in the 
myogenic lineage in addition to desmin. In agreement with Schaart 
et al (1989), Colley and coworkers (1990) reported that in avian 
skeletal muscle the expression of titin preceeds that of other 
myofibrillar proteins and is already present in round post-mitotic 
myoblasts surrounding the nucleus. They also showed that titin 
subsequently becomes co-localized with MHC, zeugmatin and a-
actinin in either punctate or basket-like arrays which were resistent 
to extraction with Triton X-100, thus suggesting that the proteins 
are stably associated. 
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Further results confirming the observation that titin is one 
of the first detectable muscle-specific proteins came from studies 
on other species in vivo (Van der Loop et al, 1992) and in muscle 
cell cultures (Hill et al, 1986; Van der Ven et al, 1992). The very 
early detection of titin in muscle cells suggests that this protein 
may play an important role in the morphogenesis of the myofibril. 
Another indication for this morphogenetic role was given by Isaacs 
and coworkers (1989). They studied synthesis, accumulation and 
stability of titin during early stages of myofibrillogenesis by using 
pulse-labeling with [35S]methionine and immunoprecipitation with 
an anti-titin monoclonal antibody in synchronized muscle cultures. 
From their observations they suggest that newly synthesized titin 
molecules are stable proteins that rapidly associate with the 
cytoskeleton of developing myotubes. 
The development and expression of titin during assembly 
of the myofibril has been studied in heart and skeletal muscle, in 
both embryos and cultured cells. An excellent overview is given by 
Fulton and Isaacs (1991). Detailed studies to elucidate the spatial 
and temporal aspects of expression of myogenic proteins using 
immunofluorescence studies on mouse embryonic skeletal muscle 
revealed the following sequence. At the earliest developmental 
stages that myofibrillar proteins can be detected, starting at day 9 
in embryo development, titin distribution is diffuse, in random 
punctate arrays and in linear punctate arrays that have irregular 
spacing. At this time, a-actinin, MHC and F-actin are all diffuse, 
while nebulin is not detectable. Shortly afterwards the punctate titin 
pattern becomes periodic. Punctate periodic distributions of a-
actinin, and myosin are also observed, while desmin appears in a 
filamentous distribution and nebulin is detected in a periodic 
punctate pattern. The first signs of cross-striation are demonstrated 
in the titin distribution, before MHC, actin, α-actinin and nebulin, 
while finally cross-stration of desmin is seen. 
A number of studies on myofibrillogenesis have noted a 
close conjunction between the registration of titin and myosin 
preceding that of desmin within the myofibril (Hill et al, 1986; 
Whiting et al, 1989; Colley et al, 1990). Observations of cells 
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regenerating myofibrils after treatment with taxol and colcemid 
lead to a model in which Α-bands and I-Z-I bundles form 
separately and come together through the intermediation of a 
"stress fibre-like structure" (Toyama et al, 1982). The suggestion 
that Z-line connected structures and Α-bands (myosin filaments) 
assemble independently is in agreement with the results of Fürst 
and coworkers (1989). They observed that, in day eleven mouse 
embryos, titin molecules are found in two different states of 
organization-pattern, depending upon which region of titin is 
analyzed. At their Z-line end, titin molecules are seen in periodic 
linear arrays, while at their M-line end they remain diffusely 
organized, suggesting independent organizational process for Z-line 
and M-line structures. Nebulin and myosin are periodic at this 
stage, while actin does not become periodic until day 14. 
As mentioned earlier, titin is supposed to have a role in 
organizing the length of the thick filament (Whiting et al, 1989) 
and in maintaining the alignment of myosin filaments (Horowitz 
and Podolsky, 1987), while nebulin filaments probably regulate 
thin filament length (Kruger et al, 1991; Jin and Wang, 1991). 
They ultimately form long inextensible filaments attached to the Z-
line which parallel the thin filaments. 
Recently Van der Loop et al (1992) studied the 
expression and organization of muscle specific proteins during the 
early developmental stages of the rabbit heart and compared their 
data with the literature. Compared to studies on mouse, chick and 
rat they concluded that the sequence of expression of muscle-
specific and intermediate filament proteins during cardiomyogenesis 
is species-dependent and that their expression and organization 
varies in time in different regions of the developing heart. It is 
conceivable that the same is true regarding developing skeletal 
muscle, and demonstrates that one has to be careful in comparing 
data of different species. 
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CHAPTER 3 
Myosin isoforms in hindlimb muscles 
of normal and dystrophic 
(ReJ 129 dy/dy) mice 
Reggiani С, Brocks L, Wirtz Ρ Loermans Η and te Kronnie G 
Muscle Nerve (1992) 14: 199-208. 

Myosin isolorm expression was studied in hmdlimb muscles of conlrol (Dy 
Dy) and dystrophic (dydy) mice ol (he ReJ129 strain during postnatal de­
velopment Three myosin heavy chain isoforms (fast ll-B MHC neonatal 
MHC and slow or I MHC) were idenlitied using monoclonal antibodies 
Only original fibers, ι e , fibers formed during fetal life were sludied Ne­
crotic and regenerating fibers were excluded The disappearance of neona­
tal MHC was found to be delayed in all muscles ol dystrophic mice except 
the soleus The traction of libers conlainmg I MHC was similar in conlrol 
and dystrophic animals at all ages, except during the third postnalal week 
The developmental increase in the fraction ol fibers expressing ll-B MHC 
was interrupted in dystrophic mice by two marked declines The first oc­
curred during the second postnalal week at the beginning of the mam wave 
of fiber necrosis and the second occurred at between 30 and 90 postnalal 
days 
Key words muscular dystrophy * myosin · postnatal development * mouse 
• monoclonal antibodies 
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MYOSIN ISOFORMS IN HINDLIMB 
MUSCLES OF NORMAL AND 
DYSTROPHIC (ReJ129 dy/dy) MICE 
CARLO REGGIANI, MD, LENNY BROCKS, PETER WIRTZ, PhD, 
HELENE LOERMANS, and GEERTRUY te KRONNIE, PhD 
Tlie mue,том ol die ch IIH us ol ilimmosome 
IO"'1 .imi the ІШІМІІОМ of ι he m<l\ louis ol ihr \ 
ihromosoim' 1 i;i\c опціп in the топче io niusiιι-
l.ii cK su opines uhi ih h.i\e been studied as mod­
els of liuinan Duclientic must ul.tt ihst iopln I he 
nun nit niiK (Isstiopln like ihe liuin.m (liscisi-, is 
caused In d e l e i m e ixpiession ol a 10()-krlal pio-
lem called iKstiophin ' ' Houesci the slow pio-
giession and excellent і е ц е п е г а т е ahilits make 
ihe mclx d\siropli\ a mild loi m which does nol 
produce mot»! т а Ы і п i l On the roimaiv dv (l\s-
tropln simiif;lv icsemhles ihe human disease \x-
lause ol us last progiession, ahundant conneime 
tissue inhllialion and pronounied structural dis­
organization. t-M-imialK leading lo coinplele nn-
pairinent ol musile ΓιιηιΙιοη "'' ЛІІІюицІі the 
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pathogenesis is not \et dear, e u d e m e points lo­
carli ihe loss ol miratellular caltitini homeosi.isis 
as ihe cause ol ii-llulai degenei.nion "' " ' ' ' I he 
loimer is piobabh due lo Luk ol dssiiophin m 
nulx lime, and to a set to be eluiidaled nioleiulai 
delect in the d\ mice 1)\ dssdophs htm esci, un­
like human Dui henne ihstrophs .ind п н и т е ІЖІ\ 
thstrophv, is toniplualecl l)\ delc-ttise invelinalion 
ol Ihe proximal pan ol motor n e n e s l ' '"' 
H is unlikc-lv lhat mvosin or other lonuaili le 
proteins plas a direci iole in ihe pathogenclii 
meihanism ol the disease M\osiii isolorms. how-
e\er repiesent sensinse markeis ol muscle liber 
dcw'lopincnt and adaplalion to phssiological or 
pailiologii<il conditions Л tlelailecl auahsis ol im-
osin isolonn expression during ihe (hsitophii 
pit»ess can theielore, be ol gieai help m iloui-
menting possible efleils ol alteied motor n e n e 
disihaige. different susiepubilin ol spendi liber 
Ispes io ihe disease, and inlcrainons Ыlucen de-
gencraiiM' and legenerausc pionsses 
\ shilt m isoimosin lomposmon louard slow 
isoloinis in d\/d\ homo/sgous animals has Ік-еп 
shown lis hl/simmons and Hnh1 1 1 and b\ Kmk el 
al I hese siudies, howesei. gist- onh a linuled 
piituie ol ihe alici.mon in isoimosin expression, 
Ix-iause onh aduli mut (tt- to I^-wceks olii) were 
sludied. and original libers, ic-, those loi med 
Isomyosin in Dystrophic Mice MUSC1 E & NERVE February 1992 199 
69 
during letal lile, were pooled with legenerating Γι 
bei s Moreover onl\ a lew lepicsentative libers 
weie bludied nidivicliialU \ disiimiuin between 
ongmal and legenetating fibers seems to be neces­
sary to anah/e the inlet at lion between develop 
menial alteiaiions and the lonsequcnccs ot the 
dvMiophit pHKess 
h n n (neonatal. I 01 slow, ΙΙ-Λ, and II-B) nno-
sin heaw ih.nns (MM( ) isoloims arc expressed 
dining postnatal development in lodeni limb 
musties ' \ lillh isoloim (Il-\) has been retentlv 
identihed In St Inallmo and u>-woi keis ч l J In the 
pjesent sliitlv. Í MIK jsojonns (neonata), I or 
slow, and II-B) weie ret ogni/ed In means ol spe 
tilit monotlonal annlxKlics I he f rat lion ol fibers 
ι eat ting with eat h aniibodv was detei mined at dil 
leieni ages Iioni 1 da\ allei bitth (when the dis 
ease was not vet tlinitallv evident) to Ή) tlavs. 
when both maturation and pathologv weie tom-
plete 
\ h e r the onset ol the disease, S tvpes ol fil)ers 
weie found in the muscles healtln-looking fibers, 
net ιoiu libéis, and legenetating libers Onh 
heallliv-looking hbeis belonging to the onginal 
population were studied Necrotit fibeis, vvhith 
showed aspetilit і т т ш к к іоі hemiial staining 
and legeneiating hbers which showed their ivpical 
developmental transitions, , s '" "' were not taken 
mio consideration 
MATERIALS AND METHODS 
Animals. Mite of the strain ReJltÍ'* were used 
Bietding pairs weie onginalK oblained Irom 
Jatkson l aboi atones (Bar I lai bor, Mt) I he ani-
mals were laised and mainlained at the Central 
Vnnnal I abotatoiv t)f ihe I niveisitv of Nijmegen 
Dvsirophit mice weie obtained bv breeding hct-
eio/vgous (l)v/dv) animals Ilomo/vgous (I)\/I)\) 
mice v\ere used as tontiols In tlv'dv animals, d\s-
tiopln diti not become evident until 2 weeks alter 
birth 
Io obtain musties ol voungcr dvsiiopbit ani-
mals, the method dcsciibed bv Plat/ei and 
( haseJ7 was used Λ leg was lemoved under ethei 
anesthesia, and the animal was kept alive to deter 
mine whether or nol dvsitoph) developed Ani­
mals of the following ages weie studied 1 dav, 10 
davs, M da\s, 20 davs, 30 davs, and Щ) davs 
Tissu· Preparation. Animals were aneslbeii/ed 
with ether and the tall muscles (gastrocnemius, 
plantaris, and soleus) and the tibialis anterior and 
extensor digitorum longus were excised, wrapped 
togelhei, and qiuckh do/cn in isopentane 
200 Isomyosm in Dyslrophic Мюе 
( —150oC) In mice vounger than 1 month, the en-
lire foielcg Irom knee to ankle was excised and 
Iro/en Senal transveise sections (ΙΟ-μιη thitk) 
weie cut in a civosiat (-2*JÜC0 close to the limbs 
largest cross section, ι e . at about two ihnds ol the 
distante li om ankle to knee, and placed on slides 
toated with thromit potassium sulphate and gela­
tin I he slides were kept at -80oC until use 
Immunocytochemistry. Mvosin isolorms were 
identihed using ì MMC specihc monotlonal ami 
bodies (M \b) BI· M, rcattmg with fast II-B 
М Ш , Bh-iib, leacting with neonatal MH( , and 
В \ hlY), icatting with I oi slow MH( I hese 
MAbs were gcnerouslv donated bv Pi of S Schi­
affino (I niveisitv of Padova) All 3 MAbs were 
highlv spet iht and. at the concentration used, did 
not slum a m cross leatmilv with other adult mv­
osin isolorms I h e anti neonatal MHC MAb. BF-
B(), cross reattetl with cmbrvomc МНС и I h e 
preparation and chaiattenzation ol the MAbs is 
destiibed elsewhere u ~ " 
I h e set lions were air diied Ιοί -Π minules, 
FIGURE 1. Schematic drawing of a cross section of a mouse leg 
showing the 7 locations where counting procedures were earned 
out Locations are indicated by dotted areas 
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FIGURE 2. Dystrophic mouse gastrocnemius (a) shows a cryosection of gastrocnemius from a 14-
day-old dystrophic mouse stained with anti-neonatal MHC antibody A cluster of small regenerating 
fibers is clearly visible Note the intense staining central nucleus and the irregular shape and size 
(b) shows a cryosection of a gastrocnemius from a 21-day-old dystrophic mouse stained with the 
same antibody as in (a) A cluster of regenerating fibers and a large necrotic fiber are visible 
and then incubated with one oí the antnmosm 
MmAbs in moist air for Ы) minutes at ЗТ'С After 
washing with PBS (pH 7.4) for 15 minutes at 
room temperature, the sections were incubated 
with horseradish peroxidase-labeled rabbit anti­
bodies directed against mouse immunoglobulins in 
moist air at 370C for 60 minutes. I he sections 
were thereafter rinsed with PBS for 15 minutes 
and with 1 ns HCl (pH 8.2} foi 5 minutes, and fi-
nallv stained with 3«3-diamînobcnzidme tetrahy-
drochlonde. Ihe sections were then dehydrated 
and mounted in tukit . 
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FIGURE 3. Cryosections of hindlimb muscles from control and dystrophic mice of different ages incubated with a MAb against neonatal 
MHC and with a secondary antibody conjugated with horseradish peroxidase Soleus and plantaris muscles in control (a) and dystrophic 
(b) mice at 10 days postnatally In (b) note that the structure is still well preserved and the fraction of positive fibers is higher than in (a) 
Plantaris muscle in control (c) and dystrophic (d) mice at 21 days postnatally Dystrophic alterations are clearly visible Extensor digito 
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FIGURE 4. Age-dependent venations of the total number ol the original fibers ι e fibers generated 
during letal life in 3 muscles of control (·) and dyslrophic (o) mice 
Mlcroicoplc Examination. I hi' ιηιηιΐκτ ol health\-
looking on^iiul fibers was cleicimined m Λ mus­
cles (plantaris, sok'us and cxtcnsoi digitoium Ion 
цш) ol noi mal and dvstrophic mice at all ai^es 
studied I o this puipose set lions «ere stained 
with heniatoxslin-cosm (H&b) Caie w.is taken to 
count the (IIHMS on sections cut where the cross 
section ol tlu musile was maxiiiial 
In serial sections, tut just alxne and l>elow the 
шамшаі cross section ol the leg. the jiercenlage oí 
fibcis reading with each oí the thiee MAbs was 
clctcimined in the 7 dií íerem locations mduated 
in ligure 1 In earh location, the percentage was 
delermined in a sample ol about 100 libers 1 he 
counting was repeated on 4 or > dilfeieiu sections 
obtained houi 2 or 3 diflcicnt animals Onk 
lie.ill In, original libers weic counted Regenerat-
ing IIIXTS and fibers whuh showed signs ol necro-
sis were excluded Neciotic libers weic iecogni/ed 
(bg 2B) hv then laige si/e, almost circulai shape. 
pale aspctihc immunostaining and, in case ol 
doubt, by their pale cytoplasmic staining with 
H&F 
I he lollowmg entena were adopted to recog-
ni7c regenerating libers (see I ig 2a and b) (1) ar-
langeinent in clusteis, (2) niegulai shape and 
si/e, which was, as a rule, smallei than that of 
original fibers, (3) central nucleus, (4) long-lasting 
reactivitv with anti-neonatal МПС МЛЬ, and (5) 
abundant surrotinding intctstttial connectise tis­
sue These entena allowed unambiguous recogni­
tion ol regenerating fibers in preparations irom 
10- (vers rare), 14-, and 21-day-old mice Some 
uncertanm was encounteied in piepaiations linm 
W) and 90-da\-old mice, due to the inciease in li­
ber si/e and the loss of reactmts with autineonalal 
MIK MAb I he othei criteria howevei piovicled 
a piecise diagnosis in alinosi all cases 
С ounting was accomplished bv projecting the 
sections with a drawing tul>c attached to a Zeiss 
(Oberkochen bcrmanv) unclose ope onto the thg-
in/ri ol a \iop Videoplan (Kontton, Munich, (.er-
nianv) seniiaiitoinatecl image anah/ei 
Statlstieal Analyiia. Data were expiessed as 
means and standard eriois Statistical sigmlicance 
ol the dilleience l)etween means was cleiermined 
using Student s I test I'robahilitv ol 0 0*} oi less 
was considered to be statisncalh significant 
RESULTS 
In most of our dvslrophic animals, the first signs 
of disease were obscised at аЫші 11 da\s alter 
bnth I he muscles of the chstioplut animals ex­
amined on postnatal days I and 10 showed a well-
presersed structure, at least within the resolution 
ol light micioscopv (sec t ig i panels a and b) 
Muscle fibers exlnbited homogeneous si/es with­
out the scatter, clue to the presence ol laige ne-
ci otic iil>ers and small legenerating fibers No m-
hltratmns ol interstitial connetlise tissue were 
visible I his was in accordance with pievious re­
ports that in newborn dv/d\ animals, lesions can 
be lound in the tongue muscle but sers ra ids in 
limb niuscles '" 2' 'H On the contiars, in muscles 
oí dvslrophic mice older than 14 dass the original 
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hcalthv fibets coexisted with necrotic and гецепег-
•ititi); filwrs as can be seen in figure 2 and bigure 
.Ή) and ? 
I he time course of the reduction in the total 
number ol original ht>ers in the 3 different mus­
cles is reported in 1 igure 1 A \ei\ marked loss 
o u u r r e d hemeen postnatal (lavs 10 and 14. and 
was followed b\ a further slower reduction At the 
end of the first month of postnatal life, the fiai-
tion of surviving original ÍIIH'IS was l)etween 20% 
(plantaris musile) and 4()9í (extensoi digitorum 
longlis) I itile or no reduction occurred between 1 
and 4 months 
Figures 5, 6, and 7 show age-dependent varia-
tions of the percentage of the onginal libers con-
taining dilleient isolorms of mvosm hcavv chain 
(MH( ) \ t birth, all the fibers examined were re-
active with anti-neonatal M HC MAb (hg ")) Be-
cause of the cross reactivity with embivonic M HC, 
this indu .ned the piesciicc ol neonatal V1HC or 
embivonic MHC in all fibers loiter on, a reduc-
tion of the percentage of fibers stained with anli-
neonata) MHC MAb ociurrcd in all muscles (hg 
5) I his piocess occurred verv eailv in the super-
ficial lavers ol the tibialis anterior and gastrocne 
mius muscle, where, at 10 davs altci buth, only 
'¿09r of the fillers were positive In these locations 
all ÍIIMTS Ікч.іше negative between 14 and 21 davs 
pnsinaially On the contrary, the transition was 
slower in the remaining locations, wlieie the frac­
tion ol positive fibers was 40% to 00% at 10 davs, 
and decreased to /ею at around 20 to 30 davs af­
ter birth 
In dystrophic animals, the disappearance of 
neonatal MHC was significantlv delayed in all 
muscles, except the soleus At 10 davs, when the 
degenerative process was not yet apparent (see 
fig 3a and b), the proportion of libers siameli by 
the anti-neonatal MHC MAb was significantly 
higher in dvstrophic mice than m normal animals 
1 he same difference was found at later ages 
t h e percentage of fibers reacting with anti-I 
MHC MAb is shown in figure fi Al 10 davs post-
natallv, fibers containing I MHC4 were virtuallv ab­
sent in the supeificial lavéis of the tibialis antenor 
and gastrocnemius, whereas thev represented 
one-fifth ol the fibers m the plantaris and exten-
sor digitorum longus muscles and m the deep lav-
GASTR DEEP 
3 4 12 0 I 2 5 
AGE WEEKS AFTER BIRTH 
FIGURE 5. Age-dependenl variations in the percentage of fibers reacting with a monoclonal antibody 
directed against neonatal myosin heavy chains in 7 different locations placed in leg muscles of control 
(·) and dystrophic (o) mice The locations are indicated by the following abbreviations Τ A SUP 
tibialis anterior superficial layers TA DEEP deep portion ol tibialis anterior GASTR SUP superti 
cial layers ol gastrocnemius mediahs GASTR DEEP deep layers of gastrocnemius mediahs E 0 L 
extensor digitorum longus PLANT plantaris SOLEUS soleus 
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FIGURE 6. Age-dependent vanations in the percentage of fibers reacting with a monoclonal antibody 
directed against slow MHC isoform in 7 different localions in the leg muscles of control (·) and dys 
trophic (o) mice "Rie 7 locations are indicated as specified in the legend of Figure 5 
ers ot the tibialis anterior and каміиішшіиі In 
these 4 locations, a leiuleiuy lo an age-dependent 
reduuion in the proportion o( slow MllC-comain-
ing libéis was visible and reached statistical signif-
icance ((ompanson between 10 days and 90 days) 
in the extensor digitorum longns and in the deep 
portion of the tibialis anici юг A similar reduction 
in the fraction ot slow libers during maturation of 
mouse muscles has already been descnljecl bv 
Whalenctar" 
As expected, 1 MHC-cnntaimng libers repre­
sented moie than halt ot the sampled population 
m the soleus without significant age-dependent 
variations In dystrophic muscles on posinaial dav 
10, the proportion ol IIIKTS reading with ann-l 
MHC MAb was not significantly ditferent trom 
control muscles During the mam necrosis episode 
(14 to 21 days) the proportion mcieascd in all lo­
cations except the supcrhcial layers of the tibialis 
anterior and gastrocnemius I he diflerencc be­
tween control and dystrophic muscles reached sta­
tistical signihcanre al 14 days in soleus and planta­
ris and at 21 days in the deep layers of the tibialis 
anterior and gastrocnemius At later ages (30 ю 
90 days), the difference between control and dvs-
trophic muscles disappeared 
No fibers showed rcaamtv with лип II В 
MHC antibodv .it biilh eilhei in contiol οι in dvs-
irophic mite Αι 10 davs, ihe libels containing 
II-B MHC weie less than ">()',? in all muscles ex­
cept the supcihual parts of the gastrocnenuus 
(more than W/i) and tibialis anteuoi (1Γ>9ί) (hg 
7) As expected, in the soleus no libers expressed 
II-B MHC Tlie age dt pendent im tease ol the 
II В MHC.-containing fibers reached a plateau be­
tween 20 and 'M) postnatal davs in all lot .nions ex­
cept the extensor digitorum longus and ubialis an­
terior (deep pan) where an inciease was still 
obseived at between W and 90 postnatal davs 
At postnatal day 10, there was no difference 
between control and clvstrophic animals in the 
proportion of II-B MHC-containing fibers I his 
indicates thai expression ol the adult isoform 11-B 
was not delaved, m spite ol the persistence of the 
neonatal isotorm In dvstropluc anun.ils, a inarked 
réduction of the proportion of II-B MHC.-contain-
ing fibers ÍK tun ed in all muscles at 14 postnatal 
clays I Ins decrease was lollowed bv an increase 
between 20 and '00 davs of age and, thereafter, by 
a new decrease Bv compaimg hgures 4 and 7. 
one tan observe that the lattei decrease was virtu-
ally not accompanied bv a fiber loss On the con-
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FIGURE 7. Age-dependent vanalions in the perceniage ol npers reading with a monoclonal antibody 
directed against IIB isoform ol MHC in 7 locations ol the leg muscles of control (·) and dyslrophic (^ ) 
mice The 7 locations are indicated as specified in the legend of Figure 5 
tiarv the first clctrc.isr coinurleH wnh the main 
episode ol fiber netmsis, v\hen iipproximateK 
50(/f ol (lie опціпаі hber population w.is lost 
DISCUSSION 
\n altered isomvosin disti ihunon m the skeletal 
imisiles of и ж е (strains ReJ 124 and С ")7ВІЛ)|) 
a l leded \МІІІ the d\stroph\ caused hv .t inulalmn 
of the d\ fixus has heen doiumemcd b\ se\eial 
studies " ' " - ' · - ' ' In last uuiscles of adult (oldei 
than (> weeks) dvstrophu .mimais .1 slufl toward л 
piedoniinaiue ol 1 Mil t and ІІ-Л \IHC has been 
obsencd Ibis шіцііі Ы· aunbuted to (a) a selei 
use loss ol 11-11 MHC expiessing fibers, (b) a tran 
sinon (ioni 11-11 MIK to ІІ-Л \ІН( , or (с) a hiffh 
pioporlion oí νοιιημ іецспсіаііпц fibers which 
mainlv contain slow or neonatal isonnosin 
In this studs, the analysis of М Ж isofoim ex 
pression was resti к ted to ihe original Ιι1κ*ι ¡ïopu-
lation, ι e the fibers which des clop as piimaiv or 
secondai ν цепегаіюп IIIKMS duiiiig fetal life Re-
gcneianng libers were ihcrelore excluded I he 
MIK isoloims weie idenlified b\ means ol highlv 
specific monoclonal anliboches (MAbs) at dilleicnl 
ages (Ііііпіц the deselopmcnt ol noi mal and dvs-
trophic mice I rom this analvsis, two new phe­
nomena emerged in dsstioplnc muscles (a) the 
disappearance of neonatal MHC was dclaved. and 
(b) the suppression oí Il-l! MHC -containing libers 
occulted in 2 distinct phases 
Ihe petsislence ol neonatal imosin in adult 
chsuophic muscles has been piewouslv demon-
strated '' '" [his isofonn has been found howeser. 
onlv inside icgcneraling libers In this study, a de-
layed disappcaiancc ol ucouala] M11С in healthy 
oiigin<il fibers y\as obsciycd Ibis iinchng might 
indicale eillier a delayed MHC tiansinon oi a spe­
dile loss of IIIXTS containing adult (slow oi fast) 
isoforms l· y ideile e against the lanci possibility is 
pmwded by the follow ing obsci\.nions (a) the 
iiaclionsoi fibres containing I MHC oi I I B MIK 
were unchanged al 10 days after bnth, у\|іечі the 
ditlercncc in leadiviiv lor neonatal MHC. was 
sery pronounced, and (b) no significant loss of II­
IKMS occurred in the leg muscles ol mice nuclei M 
postnatal days (see Hg .la and b and 1-ig 1) 
No clear explanation for delayed isoimosin 
transition is asailablc Neonatal to adult transition 
seems to be independent of nersous control " 
It should not. therefore, be ailectcd b\ the altered 
motor n e n e disc hai ge tale which has been ob-
seised in dystrophic m i c e " 1 ' Ihe earlier re-
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ІШЛЛІ ol multiple iiiilcuauon, which w,is found in 
d\sttophic mice ' seems also to he an tinlikeh ex­
planation 
I he sinn of the peuentajjes ol hhcis reatini^ 
unii the i dil lei ent M \l)s was цге<Иеі than KM)', 
al 10 postnatal da\s hetaiise ol the píeseme ol li-
bels нас ling »uh т о ю than one \1 \l) I he \al 
lies ho\\e\cr wcie underestimated, lieiause 11 V 
and II X \I1IC s were not itxogni/cd b\ inununo-
siaiuing llighei \aliies weie ohtatned in d\stio-
plin (I 17 ± Т * . mean ¿ S1-) than in connol (Hlh ± 
4'() mue. induaiing a moie pionouiued ioe \ -
piession of imosin isolouns. piohahK due lo dt 
]a\ed disap|X'aiame ol neonatal \ IH( with nnal-
leied exptession ol II H \1HC 
I he lai I thai ill Lived (hsappe.nance of neona-
tal МНС was not obseiwd in soli us d i señes some 
comment In last muscles such as the H)I. . tibialis 
antet un, plantai is. and gasliocnemius. both pn-
ιη,ιι\ and secondaiv ¡çeneiation libéis can expiess 
neonatal MIK. and become last fibers"" On the 
conti.и\, in the soleus pnmatv tçeneialioii libels 
aie coniinitied to cxpiess slow and einl)i\onic 
MIK ""' and onlv secondan ffcncration libéis can 
cxpiess neonatal MHC I he dilleience between 
the soleus and last illuselo iniglil sudes t th.it 
neonatal MHC persists onh in the piimaiv цепег-
ation libers ol tUstiopluc fast muscles 
1 he two phases ol the suppiession ol II-ll 
МПС-соташшц libers aie < Irai К dilleieni I he 
In si phase was associated with the massive libu 
nciiosis, which otcutted at l>etween 10 and 11 
davs 1 he second phase look place belween 'W 
and 90 postnatal davs in the presence ol a vinu-
all\ constant fiber number During this lauer 
phase, the Irailton ol fibers containing I MHC 
was constant οι slighllv decreasing \n increase in 
the Iractton ol libels coniaining II \ MHC or 
ll-X Ml 1С was, thcictotc, a necessatv compensa­
tion loi die letlutlion ol the proportion ol II-H li­
bers It is known that a liansition trom II-U MHC. 
lo II- \ MHC or II-X MHC tan be induced in fast 
muscles In denervalion or b\ a|)piO{)tiate sliinula-
lion paiterns ' " ' One ol diese patterns, the icpet-
itive high-irequencv burst,' closelv lescmbles the 
sustained multiple (list hatge l\pical ol motor 
nerves of dvstrophic mice I his latici has been 
shown lo be caused bv local amvelination " ' ' 
REFERENCES 
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1 he decic.isc ol the piopoilion of H-B MHC -
expressing libers m the mteiv.il between 10 and 
I 1 postnatal davs coincided Willi ilio loss ol alinosi 
"lO't ol ihe onginal filici population I his points 
out thai, at tins si.ige ol the disease the II,Kilon ol 
II 1) libcis which degniti,He was higher than that 
ol 1 hbets, whose реи cm.ige aiiuallv intieased 
dining that peiiod. and veis likclv also ol that ol 
II-A and l l -\ libers 1 his line ol reasoning leads 
lo the toiulusion that 11-B libels arc more sensi­
tive to the dcgoneiaiive pimess al ihe beginning 
(IO lo 14 davsl ol ihe inani nciiosis episode I Ins 
is in agreement with pies mus siudics, which 
showed a pielerenlial loss ol lasi glvtolvlie li­
b é i s 1 ' ' 4 bbc i s coniaining Il-B MHC niav then 
become less sensitive to the degeneiative pioeess 
so thai in the lollowmg week (14 to 21 davs) llicn 
lelalive pio|>oitioii increases 
\ii explanaiion loi the greatet sensitiv itv ol 
the 11-li MHC -tonlaiiiing libéis to the dvstiopluc 
process icstiicted to the penoil belween 1(1 and 
14 davs, can be onlv speculative At that age, mite 
assume an atlull postine anti begin their locomo-
toiv auiviiv It has been shown llial immobiliAi-
uoii can pi event the development ol dvsnophv Io 
a gieai exlent ' ' l)iiriiig the same penod, multiple 
inncivaiion is elinunaled ' It is known thai polv-
neuronallv miicrvated libels in spindles''' οι in cx-
liaoeulai nuiscles" are lesistanl lo die dvstiophv 
ІчпаІІ , ihe panel η ol acliviiv ol the inoior units 
exhibits a giathial dillcieniiation It this pioeess 
in the mouse' is sunilai lo thai described in the 
l a i r the thflerentiation ol inoioneiiion thschaigc 
implies a 3- to 1-Iold increase ol die firing fie-
quencv ol die last motor units and little vanalion 
ol the slow ones cliiniig the second postnatal 
week I aking uno accollili all illese lacts. one mav 
hvpolhesi/e thai the lilxts cxpiessmg 11-B M1IC 
cxliibn a siili unknown moleculai delect vvluch 
makes them pailitul.ulv iiiadee|iiaie to cope with 
the new lunclional deinanils 
In conclusion, this studv has quantificd the 
eonitibuiion ol the original hbci populalion lo the 
isomvosm slnll, which occurs m dvsuophit mue 
muscles Ihe icsulls show that altered dcvclop-
nienl til these libéis is combined with a ditfeien-
tial sensitiv it) to the disease and Willi adaptalion lo 
new leaiuies ol neive disc hai gc 
l.iteel Usi ,ІШІ slow rnt muselés J 4<-ijroen l()()(l 10 f i -
llio 
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Summary. The disinbulion of the intermedíale ПІатепі 
pioteins (Π Ρ) desmin and vimcntm was sludied in gas­
trocnemius plantaris and soleus muscles of the dys 
trophic mouse slr.iin ReJ 129 during posinatal develop­
ment Special attention was paid to the overall morpho 
logical changes in the distribution of these cytoskelelal 
constituents in degenerating and regenerating muscle 
fibres In contrast to their normal counterparts the dys 
trophic mice (ReJ 129 dy dy) appealed to develop lour 
l>pes ol distinct muscle fibres with immunohistochemi-
cally detectable aberrant IFP patterns The distnbulion 
of desmin ΙΓΡ differed in the dystrophic muscle fibres 
as compared to the normal fibres in that juxlanuclear 
aggregates of ІЬР were frequently seen In contrast to 
the recent literature we conclude that these cells are re­
generated myofibres exhibiting defective nuclear migra­
tion 
Kev words Vimentin Desmin Cytoskcleton Dystro­
phy Mouse Muscle 
Introduction 
Muscular dystrophy in the mouse strain ReJ 129 (dy d>) 
is a monofaclonal autosomal rcccssivclv inherited de­
fect For many years this strain has served as a model 
for human muscular dystrophy In the human system, 
the defective gene responsible for Duchenne muscular 
dvslrophy (DMD) has been identified (Monaco et al 
1986 Kocnigetal 1987 Hoffman et al 1987) while 
it has also been shown that the normal gene product, 
dystrophin is deficient in muscles of individuals wiih 
DMD However the expression of dystrophin is normal 
in mouse strain ReJ 129 (own unpublished observation) 
Therefore this strain seems not to be a suitable model 
for DMD but clearly suffers from a different kind of 
Ojfprint Γκμισίίί to I Brocks 
dystrophy with clinical similarities lo DMD For exam 
pie the disease is progressive and interferes with postna­
tal developmcni (Wirtz et al 1981) I he course of the 
disease in this mouse strain is unknown but abnormal] 
ties in muscle (Banker 1968 Meier 1967 Platzer and 
Chase 1964) and nerve (Biscoc el al 1975 Bradley and 
Jenkinson 1973, Jams and Bradley 1978 Bradley and 
Jaros 1979) were observed at early stages Lspecially 
during the second and third postnatal weeks the dvs 
trophic disease progresses rapidly (Wirt/ et al 1981) 
coinciding with the pcnod that the animals become mo­
bile 
Several studies have indicated that altered muscle de­
velopment may play a role in the pathogenesis of dystro 
phy in the mouse (Dangain et al 1987 Skau 1981 Tot-
sukaclal I9K1) Recentlv Reggiani et al (1991)showcd 
that isomyosin expression is allered in dystrophic mice 
At the age of 10 days even before the appearance of 
any marked histopathological features more myofibres 
with immature (neonatal) mvosin were detected as com­
pared to normal controls 
Intermediate filaments (IF) have been shown to alter 
their composition and structural organization during 
maturation ol myofibres These cytoskelelal structures 
are suggested to be functional in the maintenance of 
the ordered organization of myofibres (Gard and Lazar-
idcs 1980) but in addition also for establishing the lateral 
registry of the sarcomeres Ihe main componen! of 
neonatal and adult muscle IF is desmin (1 azandes 1978 
1980 Thornellctal 1981) Muscle fibre differentiation 
is accompanied by a prolound redistribution ofcyloske 
letal componcnls parallelled by a switch in gene expres 
sion In myoblasts a major II protein is vimentin Gene 
expression of this protein is suppressed upon differentia­
tion while desmin gene expression is up regulated (Wha 
len et al 1976 Gard and Lazandcs 1980 Fischmanand 
Danto 1985) 
Only a lew workers have invesligatcd the possible 
involvement of these IF proteins in the pathogenesis of 
muscular dystrophies (Thorncll et al 1980 1983) In ihe 
present investigation the expression of desmin and vi-
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Fig. 1. Imiminofluorographs of muscle from 3 days a. b and 
2 months old c, d normal mice in serial transverse sections viewed 
by сопГоса! scanning laser microscope (CSLM) stained for \imen-
tm [blue-green) and DNA {orange) a, c. or desmin {hluc-green) 
and DNA [orange) b. d Whin arrow indicates a myofibrc m opti­
mal cross section showing a lluorcscent intermyoHbrillar network 
Black armn indicates a myofibrc, with a fluorescent pattern of 
concentric circles Magnification iOO χ 
menlin was studied during normal and dystrophic post­
natal development of mice up lo 2 months. The aim 
of this study was to examine whether or not altered 
IF protein expression or an altered IF protein distribu­
tion could be correlated with defective maturation of 
diseased muscles 
Materials and methods 
Animals Mice ol the ReJ 129 strain, raised from breeding pairs 
originali) obtained from Jackson Laboratories (Bar Harbor. 
Maine. USA) and maintained al the Central Animal Laboratory 
of the University of Nijmegen, were used The mice were kept 
under standardized conditions and received food and water ad 
libitum 
Dystrophic (dy dy) animals were obtained by mating heterozs-
gous (Dy dy) mice Homozygous (Dy Dy) mice served as controls 
Musile tissue preparation Animals were anaesthesized with sodium 
peniobarbital Three hindlcg muscles (gastrocnemius, plantaris and 
soleus) were excised and quickly frozen in isopentane chilled with 
liquid nitrogen Muscle tissue from mice aged 1. S. 10 II. 14-ts 
17 IS and 20 21 da>s. and 1 and 2 months were examined 
Serial transverse S μηι thick sections were cut m a Walter Dilles 
cryostat (—25° С) the sections were stored on Mullispot slides 
(How Laboratories) at - 135° С until use 
Hisuultetmsirx To assess the overall morphological changes in the 
muscle the fro/en sections were stained with Sinus red (SR) accord 
mg to Sweat el al (1964) 
Methyl green pyronin (MGP) staining according to Trcvan and 
Sharrock (19М) was used to delect RNA in regenerating fibres 
The sections were air dried for 60 mm and prclreated for 5 mm 
with phosphate buffered saline (PBS. pH 7 4) containing 0 5no Tri­
ton X-100 They were incubated with the appropriate antibody 
in a moist chamber at 37° С for 60 mm After washing twice in 
PBS for 15 mm each at room temperature the sections were incu­
bated with FITC-conjugated Swme-anti-Rabbit IgG (DAKO-mv 
munoglobuhns a s Denmark) for 60 mm at room temperature 
After two washes of 15 mm each with PBS at room temperature 
the sections were stained with 0 01 M Dhidium Bromide (EtBr) 
for 30 sec to detect the DNA and RNA After washing with PBS 
the sections were mounted in Fluorostab (Euro-diagnostics BV. 
Apeldoorn. The Netherlands) 
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Fig. 2. Inununofluorographs ol d>strophii. mouse muscle in serial 
transverse sections viewed by CSI M stained lor vimentin [blue· 
green) and DNA (orange) a, с, с. or dcsmm (blue-green) and DNA 
ifiniití-f) b, d, f Magmfícaíion КЮх a, b Two and a hall weeks 
old mouse Him к urniw s indicale cells co-expressing vimentin and 
desmin c, d Ihree and a hall weeks old mouse Black arrows indi­
cate cells co-cx pressing ν mietiti η and desmm While arrow s indícate 
small cells wiih central nuclei expressing desmin e, f Three and 
a half weeks old mouse Stan indicale desmm negative cells 
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АПІІМПІ ТЫ following poKclnnal dnlisLra were used 
— An αΠιηι(> puni ltd rjbbil mtiM-rum гаіы.с] againit viinintin 
isol«iti.d from (.all \\.пъ by paparalivi. gtl dcctrophurcsis as dc 
ttribtd h> RamaLkcrs ci al (1981) 
— Λ rabbii antiserum directed againsi chicken gizzard muscle des 
mm prepared as described by Ramackcrs el al (1981) 
Ihc spcuhuty of both antistra m mouse tissues has been extensive 
l> lestLd and proven (Pieper et al ІУ89 Schaart et al I9H9( 
Мигом ори examination The tissue seclions «.ere examined and 
phouigraphtd wilh a Lul/ MPV tompaLl fluorLSLcncc mn.rost.opc 
(WLi/lar I RO) and wiih a Lascrsharp MRC 500 confocal scan­
ning laser miLTOSLopc (Hiorad Oxlordshirc bngland) 
Results 
Í mtenfm and desmm m normal musi ie 
Vimentin staining (Fig la c) is negative in the myo-
fibres of muscles of all animals studied (from 1 days 
up lo 2 months) Vimcntm is distinctly present in con-
nective tissue cells tendons and nerves as well as m endo-
thelial cells of capillaries and larger vessels and some 
smooth muscle cells 
The distribution of desmin in myofibres of 3 day-old 
animals is coarsely granular m all muscles studied 
(Fig lb) although some slaming is concentrated around 
the Z-discs 
From the age of 14 clays onwards the mature staining 
pattern appears (Fig 1 d) ι e uniformly concentrated 
close to ihc sarcolemma with a high concentration ai 
the Z-discs appearing in a fluorescent intermyofibnllar 
network in the optimal cioss sections (Fig Id while 
arrow) or in a fluorescent pattern of concentric circles 
and parallel lines (Fig 1 d black arrow) 
I munnn anddesmm in d\ strophii musile 
The overall histological appearance shows no differences 
between muscles ol healthv and dystrophic mice up lo 
10 l ldavs Immunohistochemical staining reactions lor 
desmin and vimenlin show similar patterns in both 
healthy and diseased mice up to this age After 10 
II days vimcntm remains absent from the first genera­
tion myofibres in all animals studied However marcas 
with connective tissue proliferation (Fig 2a. с and 
Iig l b c) small strongly vimenlin-positivc cells be­
come apparent Such cells are particularly obvious in 
muscles of 14 day-old animals Staining of these cells 
with Fllir reveals a weak RNA reaction in the cytoplasm 
in addition to the strong reactivity in the nucleus where­
as incubation with methyl green pyronm (MGP) results 
in a red staining reaction in the cvtoplasm in addition 
to a green nuclear staining (results not shown) 
Vimenlin expression in nerves connective tissue ca­
pillaries and large blood vessels as well as tendons is 
similar to that observed in normal muscle tissue 
In 10 11 day-old dystrophic muscles desmin shows 
a uniform staining at the periphery and a more or less 
granular central staining in the first generation m>o-
fibrcs (results not shown) Particularlv at ihis age but 
to a lesser extent also at all later stages rounded desmin 
negative myofibres are observed Figures 2f and ih 
show this cell type in 24 and 14 dav-old animals respec-
livcly These cells are also negative for vimenlin 
(Fig 2e), and show a pale sarcoplasmic staining in Sinus 
red stained sections (Fig 3i) The latter staining reaction 
reveals nicely the contours of these desmm-negame mus­
cle fibres (compare Fig 3i j). showing that no sigmfi 
cant difference in the diameter of these cells as compared 
to normal muscle fibres exists 
In dystrophic animals of 14 days and older desmin 
shows the normal adult distribution pattern (Figs 2b 
la) In these morphologically normal * first generation 
myofibres desmin is uniformly distributed at the penph 
cry with a reticular sarcoplasmic staining (or with a 
staining pattern ol concentric circles or parallel lines) 
However next to these fibres the areas of proliferated 
connective tissue show small stronglv desmin-positive 
cells (I ig 2b d lb) When comparing these desmin 
staining patterns with the vimenlin reaction in serial sec 
lions it appears that many of these cells co-express both 
types of lb protein (compare big 2a with 2b big 2c 
with 2d and F-ig l b with 1c) 
In 17 18 day-old dystrophic animals many small 
myofibres with centrally located nuclei arc seen 
(Fig 2d) These cells show a desmin distribution pattern 
that appears lo be more mature than the desmin pattern 
observed in ihe small fibre cells which co express desmm 
and vimcntm (compare Fig I b w i l h l d le) In addition 
lo a staining pattern associated with the Z-discs these 
cells also contain centrally located desmin accumulations 
(Fig Id) or a desmin reaction surrounding the nucleus 
(Fig le) I hey are negative for vimcntm, while MGP 
gives a faint cytoplasmic slaming reaction Incubation 
wiih HBr shows ccntrallv located nuclei in the fibres 
and clearly demonstrates that the desmm accumulations 
arc associated with the periphery of the nuclei (compare 
bigs 2d and 3d) No RNA-rclatcd EtBr-fluorescence is 
seen in the fibre cytoplasm 
At the age of 21 days and older small myofibres arc 
siili evident but also many myofibres wilh ccntrallv lo­
cated nuclei are seen (Fig If g) These myohbres have 
diameters comparable to those of healthv mice of the 
same age and contain perinuclear dcsmin-aecumula-
tions or a desmin reaction surrounding the nucleus 
At Ihc age of 1 month and 2 months the total number 
of myofibres per muscle appears to be decreased while 
the relative amount of connective tissue has increased 
(data not shown) Compared to muscles of 21 day-old 
dystrophic mice 1 month old muscles contain more 
large myofibres with centrally located nuclei 
Correlation between age and thi auurnnn of tin four 
different t\pes of mustie tells m the d\ strop/in mouse 
Table 1 correlates the occurrence of the pathologically 
altered ivpcs of muscle fibres wilh the age ol dystrophic 
mice Ihe peak occurtcnce of the various aberrant 
types of muscle fibres is seen at dilferent ages oí the 
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Flg.3. Diflereni i>pes ol myofibres observed in dystrophic mouse 
muscle aller slaimny for desmin a, b, d, c. f, g, h or vimentin 
с. as referred lo m ГаЫс I i Sinus red slaimiig of the libres shown 
in j j A desmm stained section {ими? peroxidase), in order to 
reveal the tonlours of the desmm negalne cells MagniHcation 
600 χ (al m h). I 50 χ i.j 
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ГяЬк 1 С о г rel mon of immunohistothcmically defined muscle LCM 
i>pc and .ige of d>b(rophic TTIILC 
Muscle cell lypc Age in ddyb 
It I I 14 17 21 10 60 
U r g e desmm _ ^
 + + + + 
nCgl l lVC Lt l l s - - - -
Small vimentin 
and desmm - + τ + + ± + ± 
positist tells 
Small desmin 
роыіічс cells with - — + -t + τ +• 
perinuclear aggregaісь 
L arge dcMTiin 
POSKIVC (.(.IK №llh _ _ _ 4- μ 4 -
τ
4 - + 
ptrmuclcar aggregates 
t '- major (raUion + minor fraction ± sporadically prtstnl 
not prestnt 
dystrophic process suggesting a specific sequential ap 
pcarantc of these morphologically distinct types of 
fibres 
Discussion 
In normal muscle development of various animal species 
it has been shown that putative myoblasts synlhesi7e 
vimenlin as a major constituent of their intermediate 
filaments (Gard and Lazamlcs 1980) After fusion of 
myoblasts the rale of desmin synthesis increases consid­
erably while vimenlin expression decreases (Fischman 
and Danio 1985) Imdally the organization of desmin 
and vimenlin is diffuse in ihcmyolubcsbut desmin grad­
ually concentrates around the Ζ discs (Bcnneti et al 
1979 Gard and Lazaridcs 1980) 
Our results show that in the myofibrcs of healthy 
mice vimentin is absent already 1 days after birth and 
that desmin is fully organized in the myofibres around 
14 days after birth This coincides with the period of 
markedly increased animal mobility (Wirtz et al 1983) 
The expression of myosin heavy chain (MHC) also 
changes at this stage with the neonatal MHC being 
down regulated totally in the period between 14 and 
21 days after birth During the developmental stages 
the amount ol myofibres containing adult MHC types 
(slow or fast MHC) increases (Reggiani et al 1991) 
As is the case in healthy muscles it appears that dur­
ing development of dystrophic muscle vimentin is al­
ready absent in all myofibres shortly after birth Up to 
10 11 davs after birth desmin displays the same differ­
entiated organization as in normal myofibres from ho­
mozygous healthy animals of the same age Our results 
also demónstrale thai (he level of expression and mode 
of organization of desmin in histologically normal myo-
fibres which arc seen al all stages of the dystrophic 
process in addition lo affected fibres is comparable lo 
lhat observed in normal mice So with regard to desmin 
and vimenlin the cytoskeleton seems to be normally de-
veloped in non-affected myofibres of dystrophic am 
mals This is in contrast to what is seen in myosin HC 
expression during posinatal developmenl With regard 
10 the myosin HC expression Reggiani et al (1991) re 
ported a retarded maturation of all myofibres of dys-
trophic animals At ihe age of 10 davs a distinctly higher 
percenlagc of myofibres containing neonatal myosin HC 
was detected in dystrophic mice as compared to normal 
mice Using enzyme histochcmical methods for mvosin 
ATPase and oxidative activity of the myofibres Wirtz 
et al (1983) already suggested a delayed maturation of 
dystrophic myofibres 
Alter the first 14 days of life the disease becomes 
clinically evident resulting in an impaired mobility 
behaviour (Wirtz et al 1983) From 14 days on a se-
quence ol (immuno)histochemical changes can be ob-
served in the dystrophic muscles Firstly the occurrence 
of large rounded desmin negative myofibres is observed 
with their sarcoplasm staining weakly with Sinus red 
This type of myofibre is observed starling trom 10 
11 days after birth Since this type of fibre stains pale 
in Sinus red we conclude that these myofibrcs are in 
an initial phase of degeneration Also Thornell et al 
(1983) and Helhwell (1988) showed lhat necrotic myo-
fibrcs can be identified by their complete lack of desmin 
reacliviiy 
Thereafter, many small cells which are both desmin 
and vimentin positive are observed within the /ones of 
conneciivc tissue proliferation Both MGI1 and FiBr 
staining j-eactions indicale a high concentration of RNA 
in ihesc cells From the fad lhat these fibres arc observed 
only subsequently to the appearance of degenerating 
fibres we assume lhat these small fibres represent a stage 
of regeneration in the diseased muscle 
Al a slightly later stage of regeneration these small 
fibres cease vimenlin synthesis but retain a desmin reac 
tivity partially located at the Z-discs In addition they 
show either centrally located desmin positive aggregates 
or circumscribed desmin-negative areas in the centre of 
the fibre Judging from the positive DNA staining of 
the central spols it is concluded that these cells are young 
regenerating myofibres with central nuclei 
In adult animals (1-2 months old) the total number 
of myofibres per muscle has decreased This is in agree-
ment with Wirtz et al (1983) and Reggiani et al (1991) 
Also many fibres with cenirally located nuclei arc ob-
served Their average diameter is similar to that of nor-
mal muscle fibres A mature distribution of desmin is 
observed in these cells with the exception that a perinu-
clear aggregate of desmin or a desmin reaction surround 
ing the nucleus is present In our opinion these cells 
represent regenerating myofibres originating from the 
small regenerating fibre type but failing lo mature nor 
mally as concluded from the fact that migration of the 
nucleus towards the sarcolemma does not occur (at least 
not until the age of 2 months) Fven at the age of 
7 months many large myofibrcs with central nuclei are 
seen as shown by Wirtz el al (1983) Wirlz et al (1982) 
reported thai such myofibrcs with central nuclei were 
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not present in dystrophic muscle if regeneration was in­
hibited by irradiation at the pre-dystrophic phase 
Our stud> shows that the maturation ol muscle in 
d\strophic RcJ 129 mice at least as concluded from 
the expression of desmin appears nol to be delayed 
This is again not in line with observations on myosin 
HC expression by Reggiani et al (1991) who showed 
that even at the age of 10 days before an> marked histo-
pathological features can be seen more myofibrcs with 
immature (neonatal) myosin are observed in comparison 
to normal controls These contrasting results ma\ be 
explained by the fact that myosin is a late marker in 
myofibrc differentiation (Schaart et al 1989) Our re 
suits indicate that at least up to desmin organization 
dilTcrentiation of dystrophic m>ofibrcs is normal Des 
min organization is also normal in apparently normal 
myofibres Furthermore our results suggest that ihe 
myofibrcs with centrally located nuclei do not represent 
degenerating libres but are signs of myolibre regenera 
lion contraiy to what has been suggested by loisuka 
(1986 1987) who concluded thai degeneration occurs 
after the nuclei ha\e moved to the centre of the myofibrc 
In our view no migration of the nuclei from the centre 
to the sircolemma occurs (at least noi unni the age of 
2 months) in maluraling regenerating myohbrcs in dys 
trophic mice This is in agreement with Wirlz et al 
(1984) who showed that also in dystrophic mice of 
5 months many large myolibres with centrally located 
nuclei are observed and Reggiani el al (1991) 
In summary we conclude lhal degeneration of ma 
ture fibres takes place and that immature fibres are actu 
ally regenerating libres and not devclopmcntally arrested 
ones Furthermore we showed lhal cxammalion of des 
mm and vimenlin expression in combmaiion with histo 
chemie H staining on serial sections is an easv and useful 
method to identify disiinclive early stages of degenera­
tion and regeneration in diseased muscle 
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EXPRESSION OF MYOGENIC PROTEINS IN IN VITRO 
MYOBLASTS AND MYOTUBES OF NORMAL AND 
DYSTROPHIC MURINE MUSCLE. 
Lenny Brocks, Peter van der Ven, Ad M. Stadhouders. 
ABSTRACT 
The expression of several muscle specific proteins was 
studied in cultured myoblasts and myotubes ofhindlimb muscles of 
normal (Dy/Dy or Dy/dy) and dystrophic (dy/dy) mice of the ReJ 
129 strain. 
In myoblasts desmin and myosin stained in a diffuse way. 
Vimentin and TRITC-phalloidin staining reaction consisted of 
bundles of filaments, while nebulin and tropomyosin showed no 
immuno-reactivity in myoblasts. 
In the myotubes desmin showed an irregular filamentous 
pattern, with only occasionally an indication of periodicity. No 
reaction was seen with vimentin, while myosin, nebulin, 
tropomyosin antibodies and TRITC-phalloidin antiserum each 
stained in a characteristic regular banding pattern. 
No clear differences were seen in the reaction patterns of 
all the antibodies used in this study between myosatellite cells and 
myotubes in normal and in dystrophic mouse cultures. 
INTRODUCTION 
The term muscular dystrophy refers to a group of 
genetically determined diseases with progressive degeneration of 
skeletal muscle. Of the various human muscular dystrophies the 
basic defect is known only of a few, particularly of the severely 
progressive X-linked Duchenne's dystrophy (DMD) and Becker's 
muscular dystrophy (BMD), which is milder in severity. A large 
protein called dystrophin is either absent or defective (25, 19, 15) 
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in these diseases. Although it is likely that dystrophin plays a role 
in the maintenance of architecture and function of the myofibre 
membrane, the exact function of this protein is still a puzzle. 
Dystrophin is also missing in the X-linked mdx mouse muscular 
dystrophy. However, despite the homology from a genetical point 
of view with human DMD, the two conditions are both clinically 
and pathologically very different. In many other types of muscular 
dystrophy, occurring either in humans or animals, the molecular 
basis and pathogenetic mechanisms of the disorder are unknown. 
Research on animal models other than the mdx mouse is relevant to 
obtain more knowledge about basic biological processes of 
progressive muscular dystrophy, in particular to provide more 
insight into the pathogenetic mechanisms that lead to the specific 
pathology and/or tissue restauration in the various muscular 
dystrophic conditions. The Bar Harbor ReJ 129 dy/dy strain is of 
particular interest, because this model, although genetically 
different from human DMD/BMD, shows various clinical and 
histopathological similarities with human DMD/BMD. 
Muscular dystrophy in the mouse strain ReJ 129 dy/dy is a 
highly progressive, autosomal, recessive disease, caused by one 
gene. Muscle fibre necrosis, abundant connective tissue infiltration 
and pronounced structural disorganization, eventually leading to 
complete impairment of the muscle (26, 36, 31), strongly 
resembles the histopathology seen in DMD. Number of recent 
studies indicate that altered myofibre differentiation may play a 
role in the development of the disease. Wirtz et al (36), using 
enzyme histochemical methods to identify the various muscle fibre 
types, reported a delayed maturation of part of the myofibres in the 
dystrophic hindlimb muscle. Reggiani et al (29), using 
immunohistochemical techniques, showed that with regard to 
myosin heavy chain (MHC) expression, the myofibre maturation in 
dystrophic animals is retarded. The disappearance of neonatal 
MHC was found to be delayed in all hindleg muscles studied of 
dystrophic mice, except for the soleus. 
In the process of maturation of myofibres the differentiation 
of the cytoskeleton is important in constructing the ordered 
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organization in myofibrils. It is known that both desmin and 
vimentin are distributed as longitudinal filaments in immature 
myotubes, whereas during maturation, vimentin disappears and 
desmin is redistributed in a cross-striated pattern (10, 13). Brocks 
et al (4) studying mice older than 10 days of age found no 
differences in vimentin and desmin expression between normal and 
dystrophic mice. However, this does not rule out the possibility 
that altered myofibre cytoskeletal differentiation may have occurred 
during earlier stages of muscle genesis, for instance in the prenatal 
period. 
To study whether differences between normal and 
dystrophic mice can be established in the earliest stages of 
myofibre formation and differentiation, a myosatellite cell culturing 
system was arranged and the expression of a number of 
cytoskeletal and contractile proteins during early myotube 
formation was studied. 
MATERIALS AND METHODS 
Animals 
Normal (Dy/Dy or Dy/dy) and dystrophic (dy/dy) mice of 
the strain ReJ 129, originally obtained from Jackson Laboratories 
Bar Harbor, Maine, USA, were used in this study. The mice were 
kept under standardized conditions at the Central Animal 
Laboratory of the University of Nijmegen and had free access to 
food and water. 
Three week old mice with distinct clinical signs of 
dystrophy were used for isolation of myoblasts. Clinically normal 
animals of the same age were used as controls. Animals were 
killed with an overdosis of pentobarbital sodium. 
Culture media and buffers 
Phosphate-buffered saline (PBS) contained: 145 mM NaCl, 
5.4 mM KCl, 5 mM Na2HP04, 25 mM glucose, 25 mM sucrose, 
50 lU/ml penicillin, 10 ^g/ml streptomycin; pH 7.2. Incubation 
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medium contained 0.15 % trypsin (Difco, détroit, MI, USA), 0.1 
% collagenase (Sigma, St. Louis, MO, USA), 0.1 % bovine serum 
albumin (BDH, Poole, UK) in phosphate buffer. Growth medium 
(a high nutritional culture medium) was composed of Dulbecco's 
Modified Eagle Medium (DMEM) (Gibco BRL, Paisley, UK) with 
20 % fetal calf serum (HyClone Laboratories, Inc., Logan, UT, 
USA), 2 % chicken embryo extract (Flow Laboratories, Irvine, 
UK), 2 mM Glutamine (Gibco BRL, Paisley, UK), 100 U/ml 
penicillin (Gibco BRL, Paisley, UK) and 1 /zg/ml streptomycin 
(Gibco BRL, Paisley, UK). Differentiation medium (a low 
nutritional culture medium) contained 10 % horse serum (Flow 
Laboratories, Irvine, UK) instead of fetal calf serum. 
Isolation of myosatellite cells 
Hindleg muscles were excised under sterile conditions. Two 
different methods for isolation of myosatellite cells were used. 
In the first method mononucleate cells were obtained using 
essentially the protocol of Yasin et al (37). Briefly, small 
fragments of muscle tissue were kept in incubation medium at 37 
0C for 15 min. The top layer containing mononuclear cells was 
collected in growth medium. This procedure was repeated three 
times. After the third and fourth time the muscle fragments were 
triturated through a 10 ml pipette 10 times to release more 
mononuclear cells. The collected fractions were centrifuged for 10 
min, 50 g at room temperature. The pellets were resuspended in 
fresh growth medium and plated into 0 35 mm culture dishes 
(Costar, Cambridge, UK). The suspension was filtered (30 μπι 
nylon mesh) to remove possible intact myofibres and plated into 0 
35 mm culture dishes or on glass coverslips. 
An alternative second method to obtain mononucleate cells 
was used, which was essentially according to the prescription of 
Askanas (1). Briefly, the hindleg muscles were cut into small 
pieces ( ± 1 mm3 each) and put into 0 35 mm culture dishes (6 à 
7 per dish). After an abundant outgrowth of cells had emerged the 
muscles pieces were placed in new culture dishes. This procedure 
was repeated several times. An homogeneous mononucleate cell 
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layer was established by dissociating the cell cultures using a 
incubation of 2 mM EDTA in buffer for 1 min followed by a 
incubation with 0.02 % trypsin in buffer for 10 min. After 
centrifugating 5 min, 50 g at room temperature the cells were 
resuspended in fresh growth medium. 
Culturing of the cells 
Further treatment of the cell cultures obtained through 
either of the two different methods was identical. The cells were 
cultured in a humidified incubator (Heraeus, Hanau, FRG) at 37 
0C and 71/2 % CO2 in air. Culture medium was changed every 
second day. Growth medium was replaced by differentiation 
medium just before the cultures reached confluency or if myotubes 
arose. 
Immunohistochemistry 
The cultured cells were fixed three days after the 
appearance of myotubes. The petri-dishes were rinsed with PBS 
(137 mM NaCl; 13 mM Na2HP04.H20; 3 mM KH2P04; all from 
Merck, pH 7.4) and subsequently the cells were fixed in cold (-20 
0C) methanol for 1 min. The cells were then air dried for at least 
60 min. Thereafter they were incubated with one of the antibodies 
described below in a moist chamber at 37 0C for 60 min. After 
washing twice (15 min each) in PBS at room temperature the cells 
were incubated for 60 min at room temperature either with 
fluorescein isothiocyanate (FITC)- or tetramethylrhodamine 
isothiocyanate (TRITC)-conjugated Swine-anti-Rabbit IgG, or with 
FITC- or TRITC-conjugated Rabbit-anti-Mouse IgG (DAKO-
immunoglobulins a/s, Denmark), depending on the primary 
antibody used. After washing twice during 15 min in PBS at room 
temperature, the cells were mounted in Fluorostab (Euro-
diagnostics, BV, Apeldoorn, The Netherlands). 
Antibodies and reagents: 
The following antibody preparations were used: 
A polyclonal rabbit antiserum directed against chicken 
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gizzard muscle desmin (pDes). Preparation and 
characterization of this antiserum have been described by 
Ramaekers et al (27). 
An affinity purified rabbit polyclonal antiserum to bovine 
lens vimentin (ρVim). Purification and characterization of 
this antiserum have been described by Ramaekers et al (28). 
A mouse monoclonal antibody to ti tin (9D10) (35, 12, 13), 
obtained from the Developmental Studies Hybridoma Bank, 
maintained by the Department of Pharmacology and 
Molecular Sciences, John Hopkins University, School of 
medicine, Baltimore, MD, USA and the Department of 
Biology, University of Iowa, Iowa City, IA, USA, under 
contract N01-HD-6-2915 from the NICHD. 
A purified monoclonal antibody directed against chicken 
breast titin (Til) purchased from Sigma (St. Louis, MO, 
USA). Purification and characterization have been described 
by Fürst (8). 
A mouse monoclonal antiserum to striated muscle myosin 
(MF20) reacting with all sarcomeric mouse myosins (adult 
and embryonic) (2), which was a kind gift of Dr. D. 
Fischman, New York, USA. 
A mouse monoclonal antibody directed against chicken 
breast nebulin (NB2), purchased from Sigma (St. Louis, 
MO, USA). Purification and characterization have been 
described by Fürst (8). 
A mouse monoclonal antibody directed against chicken 
muscle tropomyosin (CHI) (22), obtained from the 
Developmental Studies Hybridoma Bank, maintained by the 
Department of Pharmacology and Molecular Sciences, 
Johns Hopkins University, School of Medicine, Baltimore 
MD, USA and the Department of Biology, University of 
IOWA, Iowa City IA, USA, under contract N01-HD-6-
2915 from the NICHD. 
Tetramethylrhodamine isothiocyanate-labelled phalloidin 
(TRITC-phalloidin, Molecular Probes, Inc., Eugene, OR, 
USA) was used. This reagent stains filamentous actin (F-
actin). A 3.3 μΜ stock solution was diluted 1 : 25 in PBS. 
Microscopic examination 
The cells were examined and photographed with a Leitz 
MPV compact fluorescence microscope (Wetzlar, FRG) or with a 
Lasersharp MRC-600 confocal scanning laser microscope (Biorad, 
Oxfordshire, England). 
RESULTS 
Microscopic characteristics of cultured muscle cells. 
Cell isolation according to both procedures (see Materials & 
Methods) resulted in a high fraction of fibroblastic-like cells in the 
cell cultures. Especially in dystrophic cell cultures the percentage 
of fibroblast-like cells was always extremely high (compare fig. la 
with lb). These cells proliferate much faster than do the 
myosatellite cells and therefore quickly overgrow the cell culture 
system. This may interfere in the development and differentiation 
of the muscle cells. For this reason no cultures older than 7 days 
were used for analysis. 
Myosatellite cells in dystrophic muscle cell cultures do not 
differ in morphology from those in normal cultures. They are 
spindle-shaped, mononucleate cells, with a high nucleus/cytoplasma 
ratio and are often somewhat ruffled at one or both ends. By 
simple phase-contrast microscopy the myosatellite cells are difficult 
to distinguish from fibroblastic-like cells, because the latter are 
very diverse in shape and vary from large, flat stellate cells to 
more spindle-shaped ones. 
Fusion of myosatellite cells mostly occurred before cultures 
had reached confluency. Also the exchange of the high nutritional 
culture medium by the low nutritional medium was not necessary 
to induce myosatellite fusion. Fusion results in the formation of 
syncitia containing clusters of nuclei. These syncitia matured into 
myotubes with positioning of nuclei in a central core within four 
97 
days of culturing (fig. la). Mouse myotubes are short and narrow-
shaped. This contrasts with myotubes of human muscle cell 
cultures (compare fig. la,b with 1c; see arrows). Spontaneous 
rhytmic contraction of myotubes could be observed regularly. 
Dystrophic cultures differed from normal ones in that less 
myotubes were formed. On the other hand the myotubes formed in 
dystrophic cultures were morphologically not different from those 
in normal cultures (fig. lb) with the exception that in dystrophic 
cell cultures myotubes were often shorter. 
Antibody reactivity pattern 
Although it is known that several of the antibodies used in 
this study cause profuse unspecific background staining in murine 
tissue, this was not obvious in the tissue cultures. The 9D10 
monoclonal titin, although reactive in human muscle cultures (33), 
gave no reaction in mouse muscle cultures. Also with Til 
monoclonal no positive reaction was observed in our muscle 
cultures. Til was also negative in mouse muscular tissue sections 
and in muscular tissue of other species like man (unpublished 
results). 
mononuclear cells: 
The K5 Polyclonal desmin antiserum appeared in the 
myoblasts derived from normal mouse muscle in a diffuse staining 
pattern with a random distribution of fluorescence. Non-muscle 
cells such as fibroblasts and fat cells did not stain with the desmin 
antiserum. With the K36 polyclonal vimentin antiserum 
myosatellite cells as well as fibroblastic-like cells showed an 
intense reaction, consisting of bundles of filaments in almost all 
mononuclear cells. The MF20 monoclonal myosin antibody stained 
muscle cells only. The MF20 staining reaction was mostly diffuse 
Figure 1: 
Phase contrast micrographs of cultured normal (a) and dystrophic (b) mouse and 
normal human (c) muscle cells. Arrows indicate the diameter of the myotubes. 
Magnification 120 x. 
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with a random distribution of fluorescence in the cell cytoplasm. 
The myoblasts showed no immuno-reactivity with the antibodies to 
nebulin and tropomyosin. Incubation with TRITC-phalloidin 
resulted in a staining reaction consisting of bundles of filaments in 
both mononuclear muscle and non-muscle cells. 
myotubes: 
With K5 desmin antiserum an irregular filamentous reaction 
pattern was observed (fig. 2a) running along the whole length of 
the myotube. Only occasionally an indication of periodicity in these 
filaments could be detected. No reaction was seen with K36 
vimentin antiserum. Myosin, nebuline and tropomyosin antibodies 
stained each in a characteristic regular double banding pattern (fig. 
2c,e,g). Striation of myosin was mostly weak consisting of wide 
bands (fig. 2c). Nebuline showed a strong striation pattern 
consisting of distinct pairs of bands alternating with dark zones 
(fig. 2e). The antibody to tropomyosin reacted in a pattern of 
paired bands with a distinct non-reactive zone in between (fig. 2g). 
The paired bands were separated by broad unstained regions. 
TRITC-phalloidin reagent showed strong striations in almost all 
myotubes. The striation pattern consisted of strong lines appearing 
with a relatively constant distance (fig. 2i). Sometimes a couple of 
weaker band were seen in the dark zone. Myotubes from normal 
and dystrophic mouse cultures reacted identical with all the 
antibodies used in this study (fig. 2b,d,f,h,j), which implicates that 
the antibodies used reacted to the same amount and in the same 
pattern of distribution in dystrophic myotubes as in normal 
Figure 2: 
Immunofluorescence CSLM micrographs of cultured myotubes, arisen after 
fusion of myosatellite cells derived from normal (a,c,e,g,i) or dystrophic 
(b.djf.hj) hindleg mouse muscles of 20-22 day-old mice, and cultured for at 
least three days after the first appearance of myotubes, incubated with K5 desmin 
(a,b), MF20 myosin (c,d), NB2 nebulin (e,f), CHI tropomyosin (g,h) or 
TRITC-phalloidin (i,j). Magnification 1400 x. 
1 0 0 
Y/" 
: *.'•'•* * • « 
A . Ш " В 
С _ ч . ! 5 
E F 
G ' Η 
•-* ' " " · ' .:,•-' ' • -'«Ι'../-
I J 
1 0 1 
о 
Ν) 
TABLE I: Expression-patterns of muscle specific proteins during mouse myofibrillogenesis in vitro. 


















































myotubes. With the antibodies to tropomyosin and nebuline and 
with TRITC-phalloidin, striation was found in dystrophic cell 
cultures, although less frequently than in normal ones. 
The results of the antibody staining reactions are 
summarized in table I. 
DISCUSSION 
Characteristics of antibody and reagent reactivity: 
Incubation with K5 desmin let many cells unstained. They 
presumably represent mainly fibroblastic cells and fat cells. The 
percentage of negative cells was even higher in the dystrophic 
cultures. Desmin cross-striation indicates a high degree of maturity 
of the myotubes (Van der Ven, personal communication; 33). In 
the mouse myotubes sometimes an indication of periodicity was 
seen (fig. 2a,b). Although this periodicity does not coincide with 
the length of the sarcomeres, it might indicate one of the first steps 
leading to cross-striation, i.e. the mutual arrangement of myofibrils 
and their sarcomeres. The MF20 myosin was confined to the A-
band staining sarcomeric myosin as seen in fig. 2c,d. The dark 
zone coincides with the Z-line. Kruger et al (20) showed that 
nebulin antibodies recognize epitopes within the I-band. 
Consequently the striation pattern seen with nebulin consists of a 
pair of distinct bands in the I-zone of the sarcomere (fig. 2e,f)· 
The anti-tropomyosin staining is confined to the I-band. The 
narrow non-reactive line in between corresponds to the Z-line (fig. 
2g,h). TRITC-phalloidin, staining strong lines alternated with 
weaker bands, reacts with filamentous actin (fig. 2i,j). Van der 
Ven et al (33) observed a similar reaction pattern in human 
myotubes. They suggest that the alternating weak and strong bands 
represent the thin filaments and the actin filaments beneath the 
sarcolemma at the level of the M-line respectivily. 
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Normal versus dystrophic muscle culture: 
Morphology: 
Normal cultures contained a high percentage of 
mononucleated non-muscle cells. Especially in dystrophic cultures 
the number of non-muscle cells was very extreme. This was most 
likely related to the age of the animals we used in our experiments, 
since a rapid progression of the disease can be observed during the 
second and third postnatal week. Especially during the third week 
infiltration of connective tissue and the appearance of macrophages 
and fat cells in dystrophic hindleg muscle is high. Less myotubes 
and often shorter ones were observed in the dystrophic cultures. 
We consider it likely that this is due to the high amount of non-
muscle cells interfering with the process of myosatellite cell-cell 
recognition and fusion. However, we can not exclude that other 
factors are of importance. Another possible explanation is that the 
readiness to fuse of the dystrophic myoblasts is less than of the 
normal ones due to the genetic defect. Due to a slower than normal 
process of myoblast fusion in dystrophic cultures myotube growth 
could be less than in normal cultures. Totsuka et al (31) developed 
a model, in which it is proposed that growth of dystrophic 
myofibres is defective. In their "bone-muscle imbalance" 
hypothesis they assume that an age-related aggravation in this 
imbalance, due to a defective growth of the muscle in relation to a 
normal growth of the bone, is responsible for the pathogenesis and 
progress of muscular dystrophy in the dy mouse. In the light of this 
hypothesis our findings are of interest although better methods to 
exclude the interference of non-muscle cells juring myotube 
formation are necessary to elucidate this point. 
Antibody reactivity pattern: 
In the present investigation the expression of several 
cytoskeletal and contractile muscle specific proteins in cultured 
myofibres of dystrophic or normal origin are compared. Several 
studies suggest that cytoskeletal proteins are important in myofibre 
development and differentiation (7, 34). Coexpression and 
sometimes even colocalization of different Intermediate Filament 
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(IF) proteins is a common feature in developing embryonic tissues 
including skeletal muscle (3, 10). The expression of one protein 
can even trigger the appearance or differentiation of another (6, 9). 
In the early stages of myofibrillogenesis the IF protein vimentin is 
expressed in the developing muscle cells, either without or in 
combination with desmin (3, 6, 9, 10). Hill et al (14) observed that 
titin and myosin synthesis and their assembly into ordered striated 
filaments are linked during myofibrillogenesis in postmitotic 
mononucleated myoblasts. Colley (6) also showed that titin is 
already present in postmitotic myoblasts. They observed that titin 
appeared around the nucleus in a stable basket-like distribution and 
suggested that this protein could play an organizing role during 
subsequent early stages of myofibrillogenesis. Another indication 
for this organizing role of titin is given by Schaart et al (30), who 
showed that in mouse embryos cross striation of titin precedes 
differentiation of desmin. In our study no qualitative differences 
were found between normal and dystrophic cultured myotubes with 
the antibodies and antisera we used. Although less frequently 
striation was observed with the antibodies to tropomyosin and 
nebulin and with TRITC-phalloidin. The basic explanation for this 
phenomenon is the same one as for the earlier mentioned shorter 
myotube formation in dystrophic than in normal cultures. Due to a 
high amount of non-muscle cells interfering with myoblast fusion, 
or a lesser than normal readiness of dystrophic myoblasts to fuse, 
myotube formation could be a slower process in dystrophic 
cultures, although started at the same time as in normal cultures. 
This results in the presence of more different stages of 
differentiating myotubes and consequently less striation (striation is 
seen in later stages in the differentiating process). Further study is 
needed to elucidate if myofibre development and differentiation in 
normal and dystrophic muscle are different in these early stages. 
Our earlier studies (29, 36) showed a difference in 
maturation of dystrophic myofibres compared with normal ones. 
An explanation that such a difference was not significantly present 
in these culture studies could be that differentiation of the 
myofibres in vitro is not far enough to elucidate a possible missing 
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protein. Nerve supply, normally involved in maturation of 
myofibres and not present in culture, could also be an important 
factor. 
In dystrophic dy animals muscular tissue damage becomes 
strongly progressive at the time the animals become more active, 
i.e. walking activity becomes more prominent. This makes it likely 
that stresses associated with contraction play a key role in the 
pathogenetic mechanisms. In this context it is of interest that in 
DMD/BMD the missing protein product dystrophin is a 
saccolemma-associated cytoskeletal protein, suggesting that the 
function of dystrophin in normal muscle is to protect the fibre by 
providing mechanical strength for the sarcolemma. Recently it has 
been shown that dystrophin-like proteins (Dmdl for Duchenne 
muscular dystrophy-like) are expressed in a wide range of tissues 
at varying levels (24). The dystrophin-related locus is on the 
human chromosome 6 that maps close to the dy mutation on mouse 
chromosome 10 (23). These findings strongly suggest that Dmdl 
are of importance in the dy muscular dystrophy. Support for this 
supposition comes from the findings that in the dy mouse both the 
peripheral nerves (16, 17) and neuromuscular junction (32) are 
abnormal, while also defects were observed in the elasticity of 
dystrophic dy muscle (5). Immunolocalization of Dmdl showed that 
these proteins were particular present in the neuromuscular and 
myotendinous junctions, as well as peripheral nerves and 
vasculature of skeletal muscle (18). These findings may be taken to 
support the suggestion that in the dy mouse defects in Dmdl 
proteins may play a key role in the pathogenesis, despite the fact 
that there is no apparent mutation or deletion in the Dmdl gene 
detected so far in dy mice (24). 
We conclude that although muscle cell cultures can be a 
useful tool to study disorders in protein expression, in our case we 
couldn't observe any significant differences between normal and 
dystrophic muscle cultures, with regard to the muscle specific 
proteins we used. New methods should be explored to get a better 
separation between muscle cells and other types of mononuclear 
cells to exclude the possible interference of non-muscle cells on 
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myotube formation and differentiation. Further study is needed to 
elucidate if myofibre growth and differentiation in dystrophic 
muscles is slowed down or in another way defective. 
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PHYSIOLOGICAL PERFORMANCE OF UNTREATED AND 
THERAPEUTICALLY TREATED MURINE DYSTROPHIC 
HINDLEG MUSCLE. 
Muscular dystrophies are disorders with a progressive 
course because the continuous degeneration and necrosis of skeletal 
muscle fibres is only partly compensated for by attempts at 
regeneration via activated satellite cells. In the mouse ReJ 129 
dyldy mouse muscular dystrophy fibre degeneration in the hind leg 
muscles is highly progressive during the second and third postnatal 
week, i.e. during the period that the animals start to walk. When 
the animals are about one month old, the disease course becomes 
moderately progressive and during the second month the situation 
is relatively stable, while hindleg dragging is obvious (see fig. 1). 
In animals of more than two months of age, disuse atrophy of 
muscles and muscle fibres prevails (Wirtz et al, 1983). 
In a number of animal models for muscular dystrophy it 
has been established that experimental procedures can modify the 
phenotypic expression of dystrophy, or alternatively can reduce or 
even halt the disease progression. For example, Karpati and 
coworkers (1982) demonstrated that early denervation of hindleg 
muscles of dystrophic hamsters (UMX-7.1 strain) results in the 
absence of necrosis and degeneration activity during the period of 
denervation. Particularly Jaros and Johnstone (1983) showed that 
early denervation of extensor digitorum longus and soleus muscles 
in the dystrophic ReJ 129 dyldy mouse results in the absence of 
necrotic changes and other histological expressions of dystrophy. 
Other surgical interventions, such as tenotomy (Wirtz and 
Loermans, 1983), muscle transplantations (Bourke and Ontell, 
1986) or transient neonatal denervation (Moschella and Ontell, 
1987) also prevented the expression of the histopathological 
features of the dystrophic phenotype. 
In developing a regime of restricted muscular use as a 
possible "therapeutic" approach, particularly those studies are 
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relevant in which less invasive procedures were applied to remove 
functional load normally exerted upon the muscles. Ashmore 
(1982) described a considerable improvement of wing muscles of 
dystrophic chickens upon immobilization in a stretched position. 
Elder (1988) examined the effects of hind limb suspension on the 
development of muscles in the dystrophic hamster (CHF 147, 
formally UMX 7.1) and found a significant reduction of 
pathological changes in nonweight-bearing dystrophic muscles. 
In a series of elegant studies Wirtz and coworkers 
(Loermans and Wirtz, 1983; Wirtz and Loermans, 1983; Wirtz and 
Loermans, 1984; Wirtz et al, 1986; Wirtz et al, 1988) examined 
short term and long term effects of immobilization as a procedure 
to modify the phenotypic expression of dystrophy in the ReJ 129 
dyldy mouse. Immobilization of normal and dystrophic calf 
muscles of young mice of the ReJ 129 strain was performed by 
casting one hindleg in such a way that the m.soleus (Sol), plantaris 
(Plant) and gastrocnemius (Gas) were relaxed, while the 
m.extensor digitorum longus (EDL) and tibealis anterior (TA) were 
stretched, i.e. with the foot in an extended position, for one week 
starting just before the beginning of the period of severe necrosis. 
It was shown that two weeks after the treatment the histology of 
the dystrophic muscles was quite normal, except for a certain 
degree of atrophy. Muscle fibre degeneration and subsequent 
necrosis was prevented, provided that immobilization was started 
before the onset of the rapidly progressive stage of the disease. 
Also long term effects were remarkably obvious. The clinical 
condition of the experimental animals and histological features of 
treated dystrophic hindleg muscles were studied after 1, 2 and 3 
months of remobilization. It appeared that in locomotion the 
experimental animals made better use of their remobilized leg than 
of the contralateral leg (fig. 1). In addition, the remobilized 
muscles were significantly less atrophic and contained more muscle 
fibres. In a further paper a detailed morphometrical evaluation of 
the effects of the early, transient cast immobilization -
remobilization process was presented (Wirtz et al, 1988). It was 
shown that immobilization of dystrophic muscles minimized 
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Figure 1 Locomotion of a dystrophic mouse (age Vh months) 3 months after 
remobilization of the right hindleg. 
pathology in both the agonists, i.e. Sol, Plant and Gas 
(immobilized in a shortened position) and antagonists, i.e. EDL 
and TA (immobilized in a extended position), although atrophy 
developed. Upon remobilization some pathology developed, but 
this was far less severely than the pathology which developed 
during the second and third post-natal weeks in the untreated 
dystrophying muscles. Muscle girth and fibre number were 
significantly increased (35% and 45% respectivily) in treated 
dystrophic muscles as compared to untreated ones. Summarizing 
these results of Wirtz and coworkers, it was shown that early cast 
immobilization resulted in both a clinical and histological 
improvement of the dystrophic condition. 
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In order to support these observations with physiological 
data, we measured force characteristics of dystrophic muscles after 
treatment. Where relevant, comparison of force characteristics 
between the three series of observations (dystrophic, untreated; 
dystrophic, treated/immobilized-remobilized; dystrophic 
treated/contralateral) is given after correcting for differences in 
morphometric parameters of the muscles. In chapters 7 and 8 
physiological properties of whole muscles were studied in situ, 
leaving innervation and blood supply intact as far as possible. 
Measurements of maximal twitch and tetanic contractions were 
carried out on the extensor digitorum longus (EDL) and tibialis 
anterior (TA) muscles in an isometric condition. Contraction and 
relaxation times, both depending on the characteristics of the 
muscles, e.g. myosin isoform composition of the myofibres, were 
measured. Attention was payed to the elasticity of dystrophic 
muscles, which is believed to be partly dependent on the amount of 
connective tissue in the muscle. 
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FORCE OF DYSTROPHIC MOUSE HINDLEG MUSCLES AND 
THE EFFECT OF EARLY IMMOBILIZATION. 
L. Brocks, H. Janssen, W. Wallinga-de Jonge and P. Wirtz. 
INTRODUCTION 
Muscular dystrophy in the mouse strain ReJ 129 is an 
inherited progressive disease. There is a continuous loss of muscle 
fibres, partly compensated through regeneration. 
The first signs of necrosis (death of single fibres and 
small groups of fibres) are found during the second week 
postnatally3. Early immobilization postpones and reduces the 
progression of the disease, provided the procedure is started before 
necrosis is observed2. The effects of early immobilization on the 
force characteristics of dystrophic muscles can be studied only 
when we know how force characteristics change during the 
development of normal and dystrophic muscles, that is without 
immobilization. Force characteristics of developing normal and 
dystrophic extensor digitorum longus (EDL) muscles are described 
here in detail. The effect of early immobilization on the force 
characteristics of normal and dystrophic EDL is shown for a 
limited number of animals. 
MATERIALS AND METHODS 
Mice 
In this study mice of the strain ReJ 129 were used. The 
dystrophic mice were bred from heterozygous (Dy/dy) animals. As 
controls either normal heterozygous animals of mice of a 
homozygous (Dy/Dy) line were used. The animals were in the 
range of 20 - 80 days of age. 
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After weighing, the animals were given an atropine 
sulfate solution (0.05 mg/ml). The mice were placed upon a heated 
table (35 0C) to control body temperature. 
Immobilization 
Animals of 7 days old were anaesthetized with ether and 
the left hindleg was immobilized by fitting a plastic cast around the 
leg and foot. The cast, fixed with plaster tape, was fitted in such a 
way that the calf muscles were in a relaxed, and the EDL in a 
lengthened position. All littermates of heterozygote (Dy/dy) parents 
were treated. The immobilization lasted for one week, adapting the 
casts to the size of the leg every other day. After this period 
remobilization was achieved by removing the cast. 
Force measurements 
Force measurements (twitch and tetanus) were carried out 
in vivo on the EDL of the left and right hindleg. The EDL was 
exposed leaving the blood supply and innervation intact. First the 
EDL of the left leg was prepared and measured, second the EDL 
of the right leg. The femur was fixed in a clamp as proximal to the 
knee as possible. The distal tendon was tied to an isometric force 
transducer (Sensotec, 500 mN). Muscle temperature was controlled 
by a constant flow of warm, moist air (muscle temperature, 36.0 
+ 1.0 0C). The n. peroneus, innervation the EDL, was stimulated 
via a bipolar stimulating electrode. Stimulation was supramaximal 
(pulse width 50 μβ). The characteristics studied at the optimal 
twitch length were: the amplitude; contraction and half relaxation 
times of the twitch; the amplitude of a 200 Hz tetanus during 200 
ms. Normal and dystrophic muscles show a smooth, stable force 
plateau upon such a stimulation pattern. 
Dystrophic muscles are very susceptible to extension. 
Lengthening of dystrophic EDL beyond a critical length appeared 
to irreversibly damage the muscle. Force (twitch and tetanus) 
collapsed, when muscles were stretched to a length a little above 
this critical length (which was found to be about comparable with 
the optimal twitch length). Therefore the optimal twitch length 
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could only be approximated, approaching it from short length. 
When active force did not increase substantially upon lengthening, 
further extension was stopped to prevent surpassing the critical 
length. 
Morphometry 
After completion of the physiological measurements, the 
muscles (left and right EDL) were excised and frozen in isopentane 
(-150 0C). The largest cross sectional area of the muscle was 
measured, using serial frozen cross sections (10 μπι). 
RESULTS 
Body-weigths of the dystrophic animals were compared 
with those of normal littermates. In control mice growth was 
considerable during the postnatal period of 20 to 50 days of age. 
Dystrophic mice weighed significantly less than their normal 
counterparts for all ages studied (fig.l). 
The twitch and tetanic force of normal EDL increased 
strongly during this period. The twitch and tetanic force of 
dystrophic EDL remained below normal EDL even at an age of 23 
days (fig.2). Also twitch and tetanic forces, as related to the largest 
cross sectional area, were lower in dystrophic EDL, compared with 
normal EDL (fig.3). 
The twitch contraction time of dystrophic EDL seemed to 
be a little prolonged when compared with normal EDL, but the 
differences were not significant. The twitch contraction time of 
dystrophic EDL was 8.8 + 1.2 ms (mean + SD, n=22) in 
dystrophic EDL compared with 8.0 ± 0.9 ms (n=27) in normal 
EDL. The twitch half relaxation time of dystrophic EDL was 12.4 
± 4.7 ms (n=22) and of normal EDL 8.7 ± 2.0 ms (n=27). 
As a result of early immobilization, the tetanic force of 
the remobilized dystrophic EDL of adult mice appeared to be 
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fig.l Body weights (in grams) of dystrophic and normal mice at vanous 
ages; i = dystrophic male, · = dystrophic female, i = normal 
male, о = normal female. 
fig.2 Absolute twitch and tetanic force of normal and dystrophic EDL of 
mice at vanous ages, expressed ш mN; · = twitch of dystrophic 
muscle, о = twitch of normal muscle, A = tetanus of dystrophic 
muscle, Δ = tetanus of normal muscle. 
fig.3 Twitch and tetanic forces relative to cross sectional area of normal 
and dystrophic EDL muscles of mice at vanous ages, expressed m 
mN/mm2; · = twitch/cross sectional area of dystrophic muscle, о = 
twitch/cross sectional area of normal muscle, A = tetanus/cross 
sectional area of dystrophic muscle, Δ = tetanus/cross sectional area 
of normal muscle. 
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higher than of the dystrophic EDL of the contralateral, non-treated leg. The 
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fig.4 The effect of early immobilization on the twitch and tetanic forces of 
normal and dystrophic EDL muscles of mice at vatious ages. The 
ratio between the treated and non-treated leg of an animal is 
expressed against its age. · = twitch ratio dystrophic EDL, о = 
twitch ratio normal EDL, A = tetanus ratio dystrophic EDL, Д = 
tetanus ratio normal EDL. The drawn line expresses the non-effect 




It has to be noted that different strains of mice vary in 
onset and progression of the disease, therefore we only can 
compare our work with that of Douglas and Baskin1 keeping in 
mind that they made their measurements in vitro. 
In our experiments the isometric contractile force of 
dystrophic EDL was weaker than that of normal EDL, also when 
expressed relative to the largest cross sectional area. Douglas and 
Baskin1, too, showed that force in dystrophic EDL is reduced 
related to normal muscles in mice at ages of 1 to 12 weeks. Body-
weights of our animals as well as twitch and tetanic forces of the 
dystrophic and normal EDL are in agreement with the results of 
Douglas and Baskin1. 
The contraction and relaxation times of dystrophic EDL 
appeared a little prolonged with respect to normal EDL, but the 
differences were not significant, in accordance with Douglas and 
Baskin1, who revealed a slight but non-significant prolongation of 
contraction time of dystrophic EDL. On the other hand they 
showed that relaxation time was significantly prolonged (30.6 %) 
As an effect of early immobilization, the muscles has an 
increased tetanic force compared with untreated muscles. 
Surprisingly we could not find the same effect for the twitch force. 
We need further experimental information to find an explanation 
for this, and to link the present results to the positive effect of 
immobilization on the functioning of the dystrophic leg muscles4. 
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Summary. Hindlcg muscles of dystrophic (ReJ 1 2y dy/dy) mice were immobilized during the 
setond post-natal week Two months after remobili/ation histopathological leatures and 
isometric torce characteristics of the in extensor digitorum longus (FDL) and the m tibialis 
anterior ('1 A) were studied Asd result of edrly trdnsient immobilization signilicant differences 
were observed in muscle morphology and isometric force compdred with untrcdtcd dystrophic 
muscles Restriction of dynamic use ol the muscles during this second post natal week largely 
prevents the muscles of dystrophic mice from becoming affected by the disease process Kven 
after two months ol remobilization pathology appears to be reduced 
Keywords murine muscular dystrophy immobilization, twitch tetanus, isometric force 
Muscular dystrophy in the mouse strain ReJ 
129 dy/dy is an autosomal recessively 
inherited defect, caused by a single gene The 
aetiology of the disease has not been deter-
mined The course of the disorder is progres-
sive and interferes with post-natal develop-
ment (Wirtz et al 1983) Abnormalities in 
muscle such as muscle libre necrosis accom-
panied by macrophage invasion and inliltra-
tion of librous tissue (Banker 14(18. Meier 
1967 I'lat/er & Chase 1964) and nerve, 
such as reduced numbers of myelinated 
axons in spinal and cranial roots and exces-
sive widening of the nodes of Ranvier(Hiscoe 
et al 197S, Bradley & Jaros 1979 Bradlev & 
Jenkinson 197 j), were observed During the 
second and third post-natal weeks when the 
animals become more active, the disease 
progresses most rapidly (Wirtz et al 198 ;) . 
Several experimental procedures have 
been described that have a positive influence 
on (he course of the pathological processes. 
providing these procedures are performed 
before the onset of the rapidly progressive 
stage Karpati et al (1982) observed that 
denervation of muscles of dystrophic hams-
ters (UMX-7 1 stram) results in the absence 
of necrosis and central nutleation. Teno-
tomy of muscles of dystrophic mice (ReJ 129 
strain) was found to prevent the disease from 
developing (Jaros & Johnstone 1984. Wirtz & 
Loermans 1984) 
Similar results can be obtained when 
hindleg muscles of dystrophic mice are 
immobilized early during post-natal develop-
ment (Loermans & Wirtz. 198 5, Wirtz ft al 
1986, 1988) Immobili/ation has an advan-
tage over denervation or tenotomy in that it 
Correbpondence I Brocks Department of Cell Biology and Histology baculty of Medical Sciences. 
University of Nijmegen St Adelbertusplein 1 6500 UB Nijmegen 1 he Netherlands 
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L Brat кь et al 
is d non invcisne method und ьо possible 
operdtive ddiridge to nerves or tendons is 
dvoided I arly immobili/dtion of dystrophic 
mouse muscles Idrgely pre\ ents the dc\ elop-
ment of pathological changes in the muscles 
and provides an opportunity to study lunda-
mentdl aspects of dystrophy such as physio 
logical or metabolic properties and to allow 
research into the efficacy of potential thera­
peutic treatments such as increased or 
reduced use of muscles 
1 he aim of this study was to examine 
w hether early immobili/ation has a beneli-
cial effect on the force characteristics in 
relation to the morphology ol dystrophic 
muscles after a period of remobili/ation It is 
demonstrated that the improved morphol 
ogy lound after treatment relates to an 
improved functional capacity of the muscles 
investigated 
Material and methods 
VI it e of the strain KeJ 129 were used The 
dystrophic (clv/cl>) mite were bred from 
hetero/vgous (l)v/dy) animals Healthy (l)v/ 
Dy) mite bred I mm homozygous (Oy Dv) 
animals of the same strain were used as 
ton trois 
Seven-day-old mite were anaesthcti/ed 
with ether and the right hindleg was immo-
bili/ed by littmg a plastit tast around the leg 
and foot 1 he tast tixed with plaster tape 
was fitted in such a way that the talf musc les 
were relaxed and the m extensor digitorum 
longus |H)I ) and m tibialis anterior (IA) 
were in lengthened positions (loermans & 
Wirt/ 1985) All littermates ol hetero/ygote 
(Dy/dy) parents were treated 1 he immobili­
zation lasted for one week and the casts were 
adapted to the size ol the leg every other day 
After this period remobilization was 
achieved b> removing the tast 
After two months of remobili/ation force 
measurements (twitth and tetanus) were 
tamed out ш vivo (VVallinga de Jonge ci al 
1980) on the I DI, and 1A of both hindlegs 
Ihese two musties were chosen betause of 
their ease m preparation for physiological 
experiments (innervation of both muscles 
occurs by the same nerve) I urthermore 
tompanson of two muscles with dillerent 
funttions provides a more tomplele pitture 
ol the effects of the treatment I DI and ГА 
both dorsiHex the foot but they differ in 
function m that the I DI pronates the foot 
and the 1A supernates it As controls we 
measured both hindlegs ol treated and 
untreated healthy mite and untreated dys­
trophic ones Ihe muscles were exposed 
leaving the blood supply and innervation 
intatt first the right leg muscles and subse 
quentlv the left leg muscles were prepared 
and measured The femur was tixed in a 
clamp as proximal to the knee as possible 
Ihe distal tendon ol the muscle to be mea­
sured was tied to an isometric force trans­
ducer (Statham green tell 22S0 mN) 
Mustie temperature was controlled by a 
constant How of warm moist air (muscle 
temperature ?(io_Lio°C) Ihe nervous 
peroneus innervating both the H)I and the 
IA was slinuilated with a bipolar stimulat­
ing elettrodt using a drass stimulator con-
netted to a constant current unit Stimula­
tion was supramaximal (pulse width 50 /is) 
Ihe tharattenslics studied at the optimal 
twitth length were the amplitude contrac­
tion and half relaxation limes (CT and yR 1 ) 
of the twitth and the amplitude of a 200 H? 
tetanus during 200 ins Normal and dystro­
phic muscles show a smooth stable forte 
plateau upon such a stimulation pattern lo 
prevent fatigue of the muscles twitth stimu 
lation was restricted to onte a minute while 
after a tetanus a rest period of 10 min was 
maintained 1 irst the IDI was measured 
then the TA borte was retorded on a 
lektronic storage ostillostope 
Dystrophit musties are very susceptible to 
extension I engthemng beyond a critical 
length appeared to irreversibly damage the 
mustie 1 orce (twitth and tetanus) colldpsed 
when muscles were stretthed past this triti-
tal length whit h was found to be about the 
optimdl twitch length 1 herefore the optimal 
twitth length could only be approximated 
approathing it from a shorter length When 
active forte did not increase substantially 
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Immobilization of di^trophu mome imtsiles 
upon lengthening further extension v\ds 
stopped to prevent exceeding this critical 
length 
After completing the physiological 
measurements the muscles were excised and 
quickly frozen in liquid nitrogen chilled 
isopentanc ( - ι >o0C) Transverse frozen 
sec tions of ι о /<m of the muscles were cut in a 
Oittes cryostat ( 2S0C) They were used for 
morphometnc and histopathological evalu 
cition I he largest cross-sec lional area of the 
muscle was measured and the number of 
fibres in this section was counted (IDI) 
Statistical analysis for comparison between 
the remobih/ed leg muscles and the contra­
lateral leg muscles was made using the 
paired t test I о compare the remobilued leg 
muscles with the nalurally dystrophic 
(untreated animals) leg muscles the two-
sample t test was used The average of the 
values measured in both hmdlcgs of the 
naturally dystrophic mice was used for 
lurther evaluation 
Results 
In remobili/ed muscles morphometnc para 
meters i e largest tross-sectional area of! 1)1-
a n d ! A muscles and libre number of the 11)1 
(ΊΑ not determined) were significantly less 
reduced by the djstrophic process than in 
untreated musc les of either naturally dystro­
phic mice or in those of the contralateral 
(parallel) leg ol treated animals (fables l and 
2) In the remobili/ed hDI the number of 
libres per cross sectional area tended to be 
greater than in naturally dystrophic «mi­
mais Microscopic observation showed that 
the amount ol connective tissue was greater 
in untreated than in treated muscles (I ig τ ) 
whereas morphometnc analysis to evaluate 
the histopathology showed the mean cross-
sectional area of the muscle fibres to be the 
same This was not obvious from the libre 
number to cross sectional area ratio because 
the measured cross sectional area includes 
fat and connective tissue 
Table t bxpenmenlal data on the extensor digilorum longus (H)I ) ol 2 > month old 
naturally dystrophic (untreated) апплаК (dy dj ) (column 2) and treated animals (dy/ 
dy) (columns } and 4) (mean±sd ) bor the latter data tor both the contralateral 
(untreated) (column 5) and the remobilized H)I (column 4) are given Data for 
healthy control animals (l)v Dy) are given m column 1 
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Fig. τ. Cross-sections through the extensor digitorum longus ( left side I and the tibialis anterior (right side ) 
muscles of b. a dystrophic animal alter 2 months of remobilization and a. corresponding regions of the 
contralateral, untreated leg. In the remobilized leg. the normal structure is better preserved whereas In 
the contralateral leg. a large amount of fat and connective tissue is present. Haematoxylin and eosin 
staining ofa io-;im frozen section. X470. 
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The maximal tv\itch force of the remobi-
li/ed musi к s was increased in the I A but 
not signifiecintly in the H)l when compared 
with untreated muscles letame force was 
signihecintly greater in the I 1)1 and ГА 
muscles of remobih/ed legs As a result of 
early immobilization the overall condition of 
the animals w as better w hich w as expressed 
in higher bodv weights than the natural 
dystrophit animals I he functional implied 
turns of transient immobili/ation ean be 
deduced Irom the force to body weight ratio 
I he tetanic force to body weight ratio ol the 
IDI and 1A and the twitch torce to body 
weight ratio of the 1A were significantly 
improved upon transient immobili/ation In 
remobih/ed IA muscles the ratio of force to 
muscle e ross-seclional area wassignihcantly 
higher than in untreated muscles on the 
contralateral side of the same animal 
Discussion 
Our experiments show that early immobili­
zation improves the isometric force of dystro 
phic muscles as compared with both conlra 
lateral and natural dystrophic untreated 
controls letame tension improved signili 
eantly ((·)' and e)S% increase m 11)1 and IA 
respectively) in remobilized muselés com 
pared with untreated LD1 and ГЛ (contraía 
teral as well as naturally dvstrc phie) I witch 
tension was also higher bv 29% (11)1 | to t )S% 
(IA) Morphometnc data reveal that the 
improved physiological performance 
observed in the muscles could be attributed 
to a retardation of the disease process i e ol 
hbre damage as a result of carlv transient 
immobilization Most investigators report 
that dvslrophy has little or no effect on 
contraction time (CI) (Douglas & Baskin 
1971 dordtm & Stem 1982) but causes a 
signihcant increase ol hall relaxation time 
( T R I ) (Douglas & Haskm 1971 1'arslovv <S. 
Parrv 1981) Our results show ed that С 1 and 
2 RT of dystrophic LDI was slightly prolonged 
with respetl to normal 11)1 (1 a b l e t ) but (he 
differences were not significant Dystrophic 
1A however showed no significant differ­
ences in CI and T R I when compared with 
normal Ί Α ( table t) It is conceivable that 
the care taken not to overstretch the dystro 
phic muscle libres explains the differences 
between the present observations and those 
of other investigators 
Although the precise genetic defect in this 
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dystrophic model remains to be determined 
there are at least indications that the degree 
of differentiation of the muscles relative to 
the time ol purposeful innervation i e matu 
ration of the motorneuronal system (thus 
indiuing high muscle activity) is an impor 
tant causal factor Vloschella and Onlell 
( 1987) suggested a critical period of develop­
ment existed v\ hich they named the \\ indou 
ol vulnerability During this period the d\s-
trophic phenotype is expressed when myo-
libres are innervated 
I he data presented here support the view 
that musc le libre damage is а с onsequence of 
relative overload especiallv during a par 
ticular critical period of post natal develop­
ment We believe that relative overload of the 
muscles is a consequence of retarded de 
velopment of the dystrophic muscles Others 
also have postulated that muscle develop 
ment m dystrophic mice is retarded (Dangain 
cl ill 1987) Reggiani ( I H / (1992) demon­
strated that isomyosin HC expression is 
altered in dystrophic animals bven at the 
age of 10 days i e before an> marked 
histopathological features such as muscle 
fibre necrosis and connective tissue infiltra­
tion are apparent relatively more myotibres 
contain immature myosin HC isolorm than 
do healthy ones 
Heerschap (t n/ (1988) in their in-vivo 
NMR study lound that the l'cr'I' (phospho-
creatine to inorganic phosphate) ratio 
increased more slowly in dystrophic mice 
alter 7 post-natal days than in healthy mice 
V\ irt/ (tal (1983) noted that the histoche-
mical character of dystrophic muscles 
changed in that more intermediate libres 
which according to their classification are 
more immature were found 
Recent studies of dynamic functions of 
healthy muscle showed that damage due to 
overload is not a characteristic reaction of 
diseased muscles Salmmen and Vihko 
(1985) McCully and I aulkncr (1984) and 
taulkner cf al ( τ 9 8 s ) demonstrated that 
normal healthy muscles fibres are damaged 
when threshold values are surpassed 
I he results suggest that some muscle fibre 
differentiation is essential to prevent muscle 
fibres from being damaged when motor 
neuron activity increases as a result of post­
natal differentiation and that in developing 
dystrophic muscles this differentiation is 
retarded barly immobilization positively 
influences the disease course by preventing 
overload of the pathological muscles during 
the sensitive period of post natal develop­
ment 
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General conclusions and remarks 

8. FINAL REMARKS AND CONCLUSIONS 
In the last chapter of this thesis we want to raise some 
issues which are relevant to the main aim of our study, namely to 
gain more insight in the pathobiological aspects of progressive 
muscular dystrophy, in as far as these may arise through defective 
maturation or differentiation of skeletal muscle cells. The issues 
chosen also indicate some avenues for further research. 
8.1 Presumed function of dystrophin and dystrophin-related 
proteins 
The discovery of the affected gene in Duchenne and Becker 
muscular dystrophy, together with the identification of its product 
dystrophin, marks a great advancement in the field of 
neuromuscular disorder research. The DMD/BMD gene appears to 
be over ten times larger than any other gene characterized to date 
and it seems very likely that the unusually high sporadic mutation 
rate in the human population can be attributed solely to the 
extremely large size of the dystrophin gene (Hoffman and Kunkel, 
1989). Dystrophin deficiency has also been documented in mice 
(Hoffman et al, 1987), dogs (Cooper et al, 1988) and cats 
(Gaschen et al, 1992). The availability of null mutant animal 
models will aid DMD/BMD research, particularly when testing 
hypotheses as to the function and interaction of dystrophin with 
other proteins. Moreover, examining the dystrophin of patients 
now allows unambiguous classification of patients as DMD/BMD 
or non-DMD/BMD. Carrier detection has also been performed 
using immunofluorescesce analysis of dystrophin, though this 
appears to be variable (Bonilla et al, 1988). 
Despite this important progress, the precise cellular function 
of dystrophin is still unknown and many aspects of the DMD/BMD 
pathophysiology await further clarification. In particular, it appears 
difficult to determine which of the numerous cellular defects might 
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be primary consequences of the dystrophin deficiency and which 
might be secondary effects. Indeed, it is possible that the primary 
function of dystrophin is served within the cells that express it, "..a 
cell autonomy of dystrophin deficiency".. (Hoffman and Kunkel, 
1989). In other words, only those cells that express dystrophin in 
healthy individuals will be subject to primary dysfunction in 
dystrophin-related dystrophy. 
Dystrophin appears to be normally expressed in all types of 
terminally differentiated myogenic cells, i.e. in all skeletal muscle 
cells, irrespective of their physiological fibre type; in heart muscle 
cells and in smooth muscle cells, both vascular and visceral. The 
only tissue in which the presence of dystrophin does not appear to 
correlate with myogenic differentiation is the nervous system. 
Given the above quotation regarding the cell autonomy of 
dystrophin deficiency, it is likely that in addition to the obvious 
defects in skeletal muscle, primary defects might be expected to 
occur in the nervous system and vasculature. It is interesting to 
note that among the countless hypotheses and theories on the 
pathogenesis of DMD, the vascular hypothesis, the neurogenic 
hypothesis and in particular the membrane theory, were by far the 
most favoured hypotheses (see review by Moser, 1984). 
Dystrophin has been found to be a cytoskeletal protein 
associated with the plasmalemma-membrane that is localized on the 
cytoplasmic surface (Watkins et al, 1988; Arahata et al, 1988). It 
also shows considerable sequence similarity and shares common 
domain organization with two other families of structural proteins, 
the a-actinins and the spectrins (Koenig et al, 1988). The amino-
termini of these proteins are thought to bind actin and the central 
domains are predicted to form a rod-like structure based on their 
conserved triple α-helical repeat motifs (Byers et al, 1989). Based 
on these similarities they have all been suggested to be members of 
the spectrin superfamily. 
Hoffman and Kunkel (1989) have recently presented a 
hypothetical model of dystrophin structure and subcellular 
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Organization: see fig 1. 
Figure 1 A hypothetical model of dystrophia structure and subcellular 
organization (adapted from Hoffman and Kunkel, 1989) 
According to this model the molecular organization of dystrophin is 
such that four different domains can be discerned, schematically 
indicated А, В, С and D. Domain A ( « 240 amino acids) 
represents the amino-terminal domain that shows great similarity 
with the analogous domain of the cytoskeletal a-actinin. This 
domain is thought to bind actin filaments. Domain В is a large 
central triple-helical domain (« 2700 animo acids) which 
resembles analogous domains in both a-actinin and spectrin. 
Domain С (« 140 amino acids) is rich in cysteines and is related 
to the carboxy-terminus of a-actinin. Domain D is the carboxy-
terminal domain ( « 420 amino acids) which shares no common 
features with any known cytoskeletal protein and is thought to 
mediate membrane association via an integral membrane 
glycoprotein. 
It should be noted that the dimerization of the dystrophin 
molecule in an antiparallel homodimeric way, as depicted in the 
model, is speculative, yet based on the sequence analogies which 
exist with both the spectrins and a-actinins and the knowledge of 
their dimerization. Dystrophin in this presumed dimeric form 
juxtaposes the amino-terminal and carboxy-terminal domains which 
likely will associate with each other or with other dystrophin 
dimers and possibly contribute to the formation of a plasmalemma-
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associated network of dystrophin dimers. This latter supposition 
seems to be consistent with immunoelectron microscopic 
observations on dystrophin distribution in skeletal myofibres 
(Bonilla et al, 1988; Miranda et al, 1988). 
As already noted, the precise cellular function of dystrophin 
is unknown. However, its extensive rod-shaped domain, its 
plasmalem ma-associated localization and its molecular similarity to 
or-actinin and spectrin, do suggest that dystrophin - much like 
spectrin in erythrocytes - stabilizes the muscle membrane structure 
and contribute to the maintenance of the plasma membrane 
integrity during deformation, for example while undergoing 
repeated cycles of contraction and relaxation. Such a role would be 
in accordance with observations on selective leakage of muscle 
enzymes into the serum, and with the occurrence of structural 
lesions in the muscle fibre plasma membrane in cases of dystrophin 
absence or deficiency (Mokri and Engel, 1975). As pointed out by 
Brown and Hoffman (1988) it is unclear whether these membrane 
abnormalities arise directly from lack of dystrophin or indirectly 
through dysfunction or displacement of the membrane proteins, 
which link dystrophin to the membrane. In either case, however, 
the deficiency must be most critical in the muscles or muscle fibres 
in which the physical stresses are the most pronounced. Such a 
correlation might possibly also explain the characteristics of DMD 
muscle fibre necrosis with regard to age dependency, muscle 
(fibre) species dependency and proximal/distal distribution of 
muscular degeneration. 
A recent study (Ibraghimov-Beskrovnaya et al, 1992) 
suggests that the function of dystrophin is to link the 
subsarcolemmal cytoskeleton through a transmembrane protein to 
an extracellular glycoprotein which binds laminin, a major 
component of the extracellular matrix. It was found that the 
dystrophin-glycoprotein complex (DGC) consists of two proteins, 
which are encoded by the same mRNA. Analysis of the nucleotide 
and deduced amino acid sequences for the two components showed 
that one DGC-protein is a transmembrane protein whereas the 
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other protein is a new extracellular laminin-binding protein. Since 
there is a dramatic reduction of the components of DGC in DMD 
and mouse mdx muscle (Ervasti et al, 1990; Ohlendieck and 
Campbell, 1991) dystrophin deficiency will lead to a loss of the 
linkage between the sarcolemma and the extracellular matrix. 
Histopathological analysis of DMD muscle fibres may be taken to 
support this hypothesis because a breakdown of the sarcolemma 
membrane precedes muscle cell necrosis and the basal lamina 
seems to separate from the sarcolemma in early steps of DMD 
(Mokri and Engel, 1975; Engel et al, 1977). 
If it is true that myofibre necrosis in muscular dystrophy is 
related to the disfunction of a cytoskeleton or dystrophin-
glycoprotein complex supporting the plasma membrane, then it 
seems likely that an analogous pathogenetic mechanism will operate 
in dystrophic conditions resembling DMD/BMD, but where 
dystrophin is not missing or deficient, as for example in murine 
129 ReJ dystrophy. 
Interestingly, a 3.5 kb cDNA, encoding a sequence which 
exhibits a predicted amino acid identity of approximately 80% with 
the carboxyl-terminal domain of dystrophin, was recently detected 
in a human foetal muscle cDNA library. This dystrophin-related 
sequence maps to chromosome 6 in man (Love et al, 1989) and the 
locus has been designated DMDL (Duchenne muscular dystrophy 
like). The mouse homologue of this gene has been designated 
Dmdl and maps to chromosome 10 of the mouse. The gene is 
located close to the dystrophia muscularis (dy) locus and this 
suggests that the Dmdl gene is possibly a candidate for the dy 
mutation and responsible for the dystrophia muscularis disease in 
the dy and dy2J mouse. 
Unlike dystrophin, which is expressed predominantly in 
muscle, Western blotting techniques reveal that the dystrophin-
related protein (DMDL protein) is found in varying amounts in 
most tissues (Khurana et al, 1990; Love et al, 1991). In order to 
establish the subcellular localization of the DMDL protein, a 
number of immunofluorescence staining studies have recently been 
performed, using polyclonal and/or monoclonal antibodies against 
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synthetic peptides corresponding to the DMDL protein (Khurana et 
al, 1991; Tanaka et al, 1991; Pons et al, 1991; Nguyen thi Man et 
al, 1991). Khurana et al (1991) demonstrated DMDL protein 
immunolocalization to the mdx mouse skeletal muscle sarcolemma, 
with high staining intensities at the neuromuscular (NMJ) and 
myotendinous junctions (MTJ), along with immunostaining of 
peripheral nerves and vasculature of skeletal muscle. Moreover 
they found that in the mdx mouse, embryonic and neonatal muscle 
fibres, as well as regenerating fibres, express far greater amounts 
of DMDL protein than do the muscle fibres in adult max mice. 
Tanaka et al (1991) demonstrated immunostaining of the 
sarcolemma in DMD/BMD and mdx but only a slight staining of 
the muscle cell membrane in control human tissue and (adult) mdx 
mice. Pons et al (1991) presented evidence that a homologue of 
dystrophin is expressed at NMJ's of normal individuals and DMD 
patients and of normal and mdx mice. Nguyen thi Man et al 
(1991), using a panel of 19 monoclonal antibodies, reported the 
presence of the DMDL protein at NMJ's in normal and mdx 
mouse. Expression of the protein was also demonstrated in smooth 
muscle, especially in the vascular system (possibly accounting for 
the wide tissue distribution observed in Western blotting). 
Interestingly, Nguyen thi Man (1991) noticed that DMDL protein 
was undetectable in the non-junctional areas of the normal control 
sarcolemma, but was present in the non-junctional sarcolemma of 
DMD patients. 
From the foregoing it will be obvious that antibody cross-
reactions within the family of related proteins are still complicating 
the interpretation of immunolocalization results and that the 
production of monoclonals, specific for the different isoforms of 
DMDL protein and dystrophin or their homologues is essential 
before confident immunolocalization is possible. Nevertheless, two 
observations are worth attention. Firstly, in all studies referred to, 
it has been shown that DMDL proteins are expressed in large 
amounts at the NMJ's. This is particularly relevant because 
histological and ultrastructural studies (Banker et al, 1979; 
Tremblay et al, 1988) have unambiguously demonstrated that the 
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Neuromuscular junctions in the 129 ReJ dyldy and dy2* dystrophic 
mice are characterized by significant atrophy of the junctional folds 
and 'retraction' of the nerve terminal. Secondly, the evidence that 
in dystrophic max mice the DMDL proteins are abundantly present 
during the embryonic and early postnatal phase, but thereafter 
strongly decrease and reach a level at the time that fibre necrosis 
starts to develop, strongly suggests a role of the DMDL proteins in 
the phenotypic expression of the disease. Such a period of 
vulnerability also exists in the dy mouse (Moschella and Ontell, 
1987; see also chapter 7 of this thesis). In conclusion, further 
research into the role of DMDL protein in the dy mouse is 
necessary to gain further insight into the pathogenetic mechanisms 
of the murine dy dystrophy and to understand the cellular 
mechanisms which compensate for deficient dystrophin-like 
molecules. 
8.2 Diverging susceptibility of mvofibres to the dystrophic 
process ? 
8.2.1 Preferential affection of fast-glycolytic myofibres in dy-
mouse and DMD 
The question has often been raised as to whether the 
dystrophic pathology involves a specific fibre type, possibly 
indicating that the DMD gene product has a specific function in a 
subpopulation of muscle fibres. Such a preferential susceptibility 
could possibly be used to intervene therapeutically in the 
progression of the disease, for example by treating with growth 
hormone inhibitors (Zatz et al, 1986). A preferential involvement 
of a subset of muscle fibres was registered by Webster et al (1988) 
in DMD. Different myofibre types distinguished by conventional 
myosine ATPase staining were further characterized 
immunohistochemically with monoclonal antibodies to MHC which 
distinguished the presence of isoforms of foetal and adult-fast or 
adult-slow myosin heavy chain in the same fibres. Their results 
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showed that the fast IIB muscle fibres were the first to degenerate 
and that extensive fast fibre regeneration occurred before the slow 
fibres were affected. Parry and Parslow (1981) showed a selective 
susceptibility of one specific myofibre type in the C57B1/6J 
dy^/dy2' strain of dystrophic mice. Fibre typing was achieved using 
histochemical staining procedures (myosine ATPase, NADH-
diaphorase). From their results it was concluded that fibres rich in 
oxidative enzymes, i.e. I and IIA myofibres, were more susceptible 
to degeneration than were IIB myofibres. 
These results also show that although the pathological 
process is not restricted to one fibre type, they do suggest selective 
susceptibility of myofibre types to the dystrophic process. 
Our own results, reported in chapter 3, show a marked 
decline in the amount of IIB myofibres (demonstrated 
immunochemically, with a monoclonal antibody directed against 
IIB myosin heavy chain) in the ReJ 129 dy/dy mouse during the 
10-14 day postnatal period. Such a marked decrease in the number 
of IIB myofibres in particular was also observed by Jaros and 
Johnstone (1984) in the dy mouse. These authors observed a sharp 
decline in the average myofibre-diameter in the dystrophic 
gastrocnemius, which is due to the appearance of many 
regenerating, young myofibres. In other words, in this muscle, 
which contains predominantly fast glycolytic IIB myofibres, 
degeneration takes place to a high rate. Wirtz et al (1983a,b) also 
decribed a sharp decline in the amount of IIB myofibres using a 
detailed histochemical classification procedure. In our opinion, 
however, this below normal number of IIB myofibres in the 
hindlimb muscles is the result of degeneration of adult myofibres 
and not, as has been suggested by Wirtz et al (1983b), a lack of 
differentiation of neonatal to adult "white" myofibres. In addition, 
our results showed that, besides degeneration of IIB myofibres, 
muscles which contain high numbers of I and IIA type myofibres 
(e.g. the plantaris and the soleus) are also strongly affected. 
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8.1.2 Fibre diameter size and risk of necrosis. 
The higher susceptibility of IIB myofibres to the 
degenerative process as shown in DMD patients and in the dy 
mouse may possibly be related to another characteristic of these 
fibre types, namely, the diameter-dimensions. Wirtz et al (1983a,b) 
showed that of the diameters the fast, glycolytic myofibres in the 
hindlimb muscles are much larger during their entire differentiation 
compared to other myofibre types. They established the relation 
between myofibre type and fibre diameter size in dependency of 
age. Close analysis of their plots shows that the fast, glycolytic IIB 
fibres are always about twice as large as the fast, oxidative IIA 
fibres and about triple as large as are the type I slow fibres. These 
data are valid for the age groups 14 and 21 days and these 
differences become even, more pronounced in the older age 
groups. If it is assumed, in agreement with the supposition of 
Karpati and Carpenter (1986; 1988), that large dystrophic 
myofibres are especially susceptible to necrosis and degeneration, 
because of an imbalance between the increasing generation of force 
and the incapacity to withstand stress, it can be explain why in the 
dy mouse in particular fast twitch glycolytic IIB myofibres are 
especially susceptible to necrosis. We will elaborate this possibility 
futher below. 
8.2 Relation between myofibre diameter and dystrophic gene 
expression. 
Karpati and Carpenter (1986; 1988) recently drew attention 
to the fact that in human DMD, as well as in murine mdx and 
hamster (CHF-147 strain) dystrophy, those myofibres whose 
diameter is less than approximately 20-25 /im (in dystrophic 
hamsters and mdx mice) are not susceptible to necrosis. 
It has been shown by a number of authors that muscle fibre 
necrosis can be prevented by using experimental procedures such 
as denervation, tenotomy and immobilization (see also introduction 
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to section II of this thesis). Such experimental procedures are 
effective not only by preventing contraction or by reducing the 
mechanical load on the muscles, but they will also interfere with 
myofibre growth or even decrease myofibre diameter as a 
consequence of disuse atrophy. Jaros and Johnstone (1984) and 
Wirtz and Loermans (1984) showed that the disappearance of 
myofibre degeneration, necrosis and the accompanying 
regeneration could be prevented in the dy soleus and the dy 
gastrocnemius by tenotomizing those muscles, and also noticed that 
the fibre diameter decreased considerably. Comparable 
observations were made earlier by Karpati et al (1982) in the 
dystrophic UMX-7.1 hamster strain. Wirtz and Loermans (1984, 
1986) showed that when a 7-day period of early immobilization 
during a critical period of postnatal development was followed by 
remobilization, the dystrophic pathology of the dy hindleg muscles 
did not occur. Even after three months of remobilization the 
animals made better use of their remobilized leg (see also chapter 
7). Wirtz et al (1988) established that in normal mice, 
immobilization of calf muscles that were fixed in a shortened 
position resulted in atrophy of about 35% of the fibres compared 
with untreated muscles, and a reduction in fibre number by about 
15%. Antagonist muscles that had been fixed in an extended 
position did not show those effects. Immobilization of dystrophic 
muscles minimized pathology in both agonists and antagonists, but 
in both, atrophy developed. 
Karpati et al (1988), studying the dystrophic mdx mouse 
found that when hind limb muscles were denervated by peripheral 
nerve section or rendered immobile by thoradic cordotomy, the 
muscle fibres remained below 20 μπι in diameter, showed no 
necrosis and a very low percentage of the fibres contained central 
nuclei. The authors ascertained that in the mdx mice necrosis does 
occur not under the following circumstances: (1) before the age of 
15 days, (2) in the rotator ocular muscles throughout life span and 
in (3) denervated or (4) severely disused muscle fibres produced by 
high thoracic cordotomy. The only common denominator the 
authors could identify was the small diameter of the muscle fibres 
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involved. This imposes the basic question about what kind of 
mechanism can protect a small diameter fibre from becoming a 
victim of the necrotizing effect of the dystrophic gene. According 
to the classical model of Hill (1938), three components are of 
importance in muscle contractile activity: a contractile component, 
a serial elastic component and a parallel elastic component. The 
contractile component is related to the contractile filaments thus to 
cell-volume. The serial and parallel elastic components are related 
primarily to the cell-surface, i.e. to the plasma membrane with 
adhering basal lamina at the outside and the suporting 
subsarcolemmal cytoskeleton at the inside. Under normal 
conditions the sarcolemma will be capable of withstanding the 
longitudinally and transversely directed strains that develop during 
contractile activity. If however the dystrophic gene defect created 
abnormality in the structure of the surface membrane, than the 
strain may lead to membrane disruption with all the deleterious 
consequences for the muscle fibre. The resistance to necrosis of the 
small diameter dystrophic fibres may then be due to the relatively 
favourable surface - to - volume ratio that prevails in these small 
myofibres. Conceivably, the defective sarcolemma of the small 
fibres will be capable of withstanding the amount of strains 
generated in these fibres. Further studies will be necessary to 
support this interesting hypothesis. 
8.3 The murine dv muscular dystrophy related to a bone-
muscle growth imbalance? 
As already indicated in the introductory chapter of this 
thesis, Totsuka and coworkers have proposed a "bone-muscle 
imbalance hypothesis" to explain the pathogenesis of dy mouse 
muscular dystrophy (Totsuka et al, 1983). At the root of their 
concept is the observation that there exists an inconsistency in the 
degree of clinical affection between the hindlimbs and forelimbs. 
The onset of the hindlimb-dragging symptom becomes manifest 
around two weeks of age and the subsequent progress of the 
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clinical condition, leading to complete functional incompetence of 
the hindlimbs, is closely related to age and growth. On the other 
hand the forelimbs, although their endurance is abnormally low, 
retain some functional capability even into adulthood. In the 
authors' opinion the basic pathology is not muscle fibre 
degeneration, but defective growth and maturation of the 
myofibres, leading to an age-related aggravation of the bone-
muscle imbalance, since in dystrophic mice the growth of the 
bones is virtually normal. 
A number of studies published by these authors support the 
view that a variation in growth capability and defective maturation 
of myofibres plays a role in the pathogenesis of murine muscular 
dystrophy (Totsuka and Uramoto, 1986; Totsuka, 1986; Totsuka, 
1987a; Totsuka, 1987b; Totsuka and Uramoto, 1988). For 
example, in a study in which myofibre diameter was analysed in 
relation to myofibre development in normal and dystrophic mice, 
aged from 2 to А г weeks (Totsuka and Uramoto, 1986), they 
showed that 'dystrophic' diameter-frequency histograms shifted to 
lower values compared to those of normal muscle. They suggested 
that "hypotrophy" rather than "hypertrophy" of fibres is a 
characteristic of the dy dystrophic muscle fibres. In addition, their 
results also revealed that only a minor fraction of the dystrophic 
fibres tended to grow continuously (max. diameters at day 14 about 
30 /urn and at day 32 about 50 μΐη). These findings were taken to 
indicate that the larger fibres are more growth-competent and thus 
"healthier" than are the smaller ones. This is at variance with the 
widely prevailing concept that hypertrophied dystrophic fibres are 
the diseased ones in a pre-state of degeneration. However, the 
authors conclused that "a variation in growth capability of 
myofibres shifted to incompetence" migth be an essential point in 
the pathogenesis of mouse muscular dystrophy. 
In a subsequent study, centronucleated myofibres presumed 
to be regenerating fibres and non-centronucleated muscle fibres 
presumed to be Original' fibres, were compared, both with regard 
to their diameter distribution and their histochemistry (Totsuka, 
1987a). It was also shown that at any age examined, the diameter 
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distribution of centronucleated and non-centronucleated myofibres 
was very similar. It also was found that central nuclei were present 
in any type of myofibres, staining either densely, palely or 
intermediately with the NADH-dehydrogenase reaction. It appeared 
also that a considerable number of centronucleated myofibres had 
peripheral nuclei and that the central nuclei tended to migrate 
neither toward the centre nor towards the periphery with age. The 
authors consider these findings as being inconsistent with the 
widely accepted view that the centronucleated myofibres in 
dystrophic muscle are regenerated. They argue that regenerating 
centronucleated myofibres are expected to have the following 
characteristics: (1) they should be much smaller than the original, 
non-centronucleated myofibres (even if they happen to grow 
normally), because they have started to grow at much later stages 
of development. (2) their histochemical stainability would be 
relatively uniform and similar to that of immature myofibres. In 
their opinion the central nucleation of fibres is a reflection of their 
defective maturation and/or the result of an injury-repair 
phenomenon which occurs segmentally along them as the muscle 
are abnormally extended. 
8.4 Degeneration - regeneration in murine dv dystrophy 
The results, reported in chapter 3 indicate a disturbed 
growth or maturation capability of the dy dystrophic myofibres and 
may therefore be taken to be in support of the "bone-muscle 
imbalance" hypothese. Indeed we registered that the disappearance 
of neonatal myosin heavy chain in dystrophic animals compared 
with normal ones is delayed. In normal animals a marked decline 
is observed after 1-2 weeks after which a complete disappearance 
is seen after 3 weeks postnatally in all muscle except the soleus. 
However, our observations concern the healthy looking fibres only 
and not the centronuclear ones. Moreover, we definitely disagree 
with Totsuka and coworkers regarding the importance of 
degeneration and regeneration phenomena in histopathological 
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alteration of dystrophying muscular tissue, and in particular with 
regard to the genesis of centronucleated myofibres in dystrophic 
muscle. As is shown in chapters 3 and 4 of this thesis originally 
healthy fibres exist together with necrotizing and regenerating 
fibres in hindlimb muscles of dystrophic mice at about 14 days 
after birth. As shown in chapter 3 the muscles of the dystrophic 
animals examined on postnatal days 1 and 10 showed a well-
preserved structure, at least within the resolution limits of the light 
microscope. In dystrophic muscles of 14 day-old animals clusters 
of small fibres are present, which showed an intense staining with 
anti-neonatal MHC antibody and possessed central nuclei. In 
chapter 4 it was shown that different forms of myofibres appear in 
a fixed order, which represents in our opinion different stages of 
the degeneration-regeneration process. Our study shows the 
presence of large desmin negative cells (first step in degeneration) 
particularly at the start of the pathogenesis at postnatal days 10-11 
alongside normal ones. Later on, at about 2 weeks postnatally, a 
striking high amount of small desmin positive centronuclear and 
very small desmin and vimentin positive myofibres are 
encountered. Only at older ages (1-2 months) large centronuclear 
myofibres are also observed. Especially striking is that spreading in 
diameter values gets higher as the animals grow older. Such a 
pattern of development of the dystrophic histopathology is nicely 
explained by the generally accepted degeneration-regeneration 
model of attempted tissue repair. 
In support of this interpretation are the results of Wirtz et al 
(1982), who presented striking experimental evidence to 
demonstrate that the centronuclear myofibres are indeed 
regenerating ones. When X-irradiation of dystrophic muscles is 
carried out at the time the myosatelite cells will become active in 
the normal course of the dystrophic progress the regeneration 
process is eliminated. No centronuclear myofibres were found in 
those X-ray treated dystrophic animals, provided irradiation was 
carried out at exactly the right time. 
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Summary / Samenvatting 

9. SUMMARY 
An important recent result of research in the field of 
neuromuscular disorders is the discovery of the genetic defect in 
patients with progressive muscular dystrophy (DMD/BMD). In 
particular, the discovery that the gene product dystrophin is located 
on the cytoplasmic side of the muscle fibre membrane has once 
more drawn attention to the key role of the plasma membrane in 
the pathogenesis of these forms of muscular dystrophy. 
Dystrophin also turns out to be absent from the skeletal and 
heart muscle cells of the dystrophic mdx mouse strain. From a 
genetic point of view, this means that the mdx model must be 
considered the ideal muscle model for DMD/BMD. However, the 
dystrophic process in these animals is clinically and 
histopathologically quite different from the process found in 
DMD/BMD. This suggests that the absence of dystrophin in mdx 
animals causes different secondary pathological changes from those 
found in human DMD/BMD. Research involving other dystrophic 
animal models is still essential in order to obtain a more 
fundamental picture of the pathogenetic mechanisms involved in the 
dystrophic process and to discover what causes the differences in 
phenotypic expression of the disease. In this connection, we believe 
that the dystrophic mouse strain ReJ 129 dy, which is both 
clinically and histopathologically rather similar to DMD/BMD, 
deserves particular attention. 
Muscular dystrophy in the ReJ 129 dy mouse strain, which 
was first described in 1955 by Michelson et al, is an autosomal, 
recessively inherited defect. The disease is progressive and leads to 
severe structural disorganization of the muscles. This particularly 
affects the hind legs (including the calf complex), leading to 
complete functional breakdown. The animals die after some 4-5 
months, often as a result of infection. 
The general introduction (Chapter 1) explains the scientific 
relevance of this dy mouse strain ReJ 129 dy/dy as a model for 
progressive muscular dystrophy in humans. It explains why a 
defect in the muscle fibre membrane is the most probable cause of 
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muscular dystrophy in this particular mouse strain. 
Since a number of studies in the literature show retarded 
differentiation and maturation of skeletal muscles in dy mice, the 
question arises whether impaired development and/or 
differentiation is part of the mechanism leading from the genetic 
defect to the specific phenotype of the dy pathology. This is the 
main reason why this study focuses on the histological and 
histochemical aspects of the prenatal and postnatal development and 
differentiation of skeletal muscles in dystrophic as opposed to 
normal mice. The chronological expression of muscle-specific 
proteins is studied in the prenatal and postnatal stages of muscle 
fibre development. 
Chapter 2 describes the normal structure of muscle fibre 
(Paragraph 2.2), and then reviews the literature on the processes 
involved in the development and differentiation of normal skeletal 
muscle fibres (Paragraph 2.3). The following aspects are discussed: 
the molecular basis of myogenic differentiation and the factors 
affecting this process; myoblast diversity and its consequences for 
the occurrence of different types of muscle fibre; the myoblast 
fusion process and the development of the various types of muscle 
fibre; and the development and differentiation of muscle fibre 
myofibrils in relation to the expression of cytoskeletal proteins. 
Chapter 2 is likewise intended as an introduction to 
Chapters 3, 4 and 5, in which the differentiation and maturation of 
dystrophic as opposed to normal muscle fibres is examined with 
reference to various muscle fibre proteins. Muscle fibre 
degeneration and the regeneration process are studied in greater 
detail in Chapter 4. 
Chapter 3 describes a study of the expression of myosin 
isoforms in the hind-leg muscles of normal and dystrophic animals 
during postnatal development. Three myosin heavy chain isoforms 
(fast IIB МНС, neonatal МНС and slow I MHC) were studied 
immunohistochemically with the help of monoclonal antibodies. 
The results indicate that the disappearance of neonatal MHC is 
retarded in all the dystrophic muscles studied, with the exception 
of the soleus. The increase in the percentage of fibres with IIB 
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МНС, which is part of normal muscle development, is found to be 
impaired in dystrophic muscles, with distinctly observable phases: 
a decrease in the percentage of IIB fibres during the second 
postnatal week, i.e. the period in which many fibres necrotize, and 
a second decrease after the fourth postnatal week. 
Chapter 4 describes a study of the occurrence of the 
cytoskeletal proteins desmin and vimentin in the hind-leg muscles 
of normal and dystrophic animals during postnatal development. 
These intermediate filament proteins were identified and located 
with the help of polyclonal antibodies. The results show that the 
differentiation of dystrophic muscles proceeds normally as regards 
desmin expression and organization. A process of degeneration and 
regeneration is also shown to occur in dystrophic muscles; muscle 
fibres with central nuclei occur as the result of a regeneration 
process, rather than defective maturation as suggested in the 
literature. 
Chapter 5 describes a study of the expression of a number 
of different muscle fibre proteins during in vitro development and 
differentiation of normal and dystrophic satellite cells and 
myotubes. The various muscle fibre proteins were identified 
immunohistochemically, using specific polyclonal and monoclonal 
antibodies. As far as the muscle fibre proteins used in this study 
are concerned, the results reveal no differences in development and 
differentiation between normal and dystrophic muscles. 
The introduction to Section II briefly discusses the 
experimental procedures used in the literature, which may 
influence the phenotypic expression of the dy dystrophy. Apart 
from a number of surgical techniques such as tenotomy and 
chordotomy, which appear to inhibit or even halt the progress of 
the disease, use is also made of non-invasive methods such as 
immobilization, in which restriction of the movement of the (hind-
leg) muscles during a given critical period leads to an improvement 
in the clinical and morphological condition of the immobilized 
muscles. In order to provide experimental physiological data which 
corroborate the observed improvement in clinical condition, the 
functional capacity of dystrophic muscles is compared with that of 
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normal muscles. In order to prevent mechanical "overloading" of 
the hind-leg calf complex during the second postnatal week (a 
"critical" period for these muscles), the immobilization technique 
chosen was the procedure developed by Wirtz and Loermans. 
Chapter 6 describes a study of the functional capacity of the 
dystrophic extensor digitorum longus (EDL) muscle during 
postnatal development. The results show that the isometric 
contractive force of this muscle in situ is less than that of the 
normal, non-dystrophic EDL at each of the ages studied. They also 
show that the contraction and relaxation times of the dystrophic 
EDL are somewhat longer, although the differences are not 
significant. 
Chapter 7 examines the effects of an early period of 
immobilization (8-15 days postnatally, followed by remobilization) 
on the functional capacity of dystrophic muscles three months after 
the treatment. The EDL and the tibialis anterior (TA) were 
examined. The results show that the isometric contractive force of 
temporarily immobilized dystrophic muscles is significantly better 
than that of untreated dystrophic muscles. Microscope assessment 
also reveals that the histology of the treated muscles is far less 
anomalous than that of untreated contralateral muscles. The 
number of muscle fibres is significantly higher, and there are no 
signs of fibrosis. 
Chapter 8 looks at a number of issues which may point the 
way towards further research. First of all, the possible cell-biology 
function of dystrophin in maintaining the integrity of the muscle 
fibre membrane during contraction and relaxation is examined. The 
possibility that the recently discovered dystrophin-related proteins 
(DMDL) play a part in the pathology of the dy dystrophy is 
discussed. Next, the "sensitivity" of dystrophic muscle fibres to 
phenotypic expression of the disorder is examined. The reasons for 
- and the differing sensitivity of the various types of fibre to - the 
initiation of muscle-fibre necrosis are discussed on the basis of the 
observation (Karpati & Carpenter, 1986) that fibres with a small 
diameter must be considered resistant to the necrotic process. The 
occurrence of the dy pathology is then discussed with reference to 
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dy pathology is then discussed with reference to the "bone-muscle 
imbalance" hypothesis advanced by Totsuka et al (1983). This 
theory presupposes defective (= restricted) opportunity for growth 
of dystrophic muscles, in contrast to normal bone growth. 
Continuing disruption of this growth balance aggravates the 
dystrophic process. Finally, the phenomenon of degeneration and 
regeneration in muscles affected by dystrophy is examined. It is 
argued that all fibres with centrally located nuclei are the resultant 
of a process of degeneration followed by regeneration; this 




Een recent en belangrijk resultaat van het onderzoek op het 
gebied van de neuromusculaire aandoeningen is de ontdekking van het 
genetisch defect in patiënten, lijdend aan progressieve spierdystrofie 
(DMD/BMD). Met name de bevinding dat het genprodukt dystrofme 
is gelocaliseerd aan de cytoplasmatische zijde van de 
spiervezelmembraan richt opnieuw de aandacht op de sleutelrol welke 
de plasmamembraan vervult in de Pathogenese van deze vormen van 
spierdystrofieën. 
Dystrofme blijkt ook afwezig te zijn in de skelet- en 
hartspiercellen van de dystrofe mdx muizestam. Vanuit genetisch 
standpunt bezien betekent dit dat het mdx model als het ideale 
spiermodel voor DMD/BMD moet worden gezien. Niettemin is het 
verloop van het dystrofe proces in deze dieren zowel klinisch als 
histo-pathologisch geheel anders dan in DMD/BMD. Dit suggereert 
dat de afwezigheid van dystrofme in mdx dieren andere secundaire 
pathologische veranderingen teweegbrengt dan in de humane 
DMD/BMD. Om een meer fundamenteel inzicht te krijgen in de 
pathogenetische mechanismen, die een rol spelen tijdens het dystrofie 
proces en om te ontdekken wat de oorzaken zijn van de verschillen 
in phenotypische expressie van de ziekte blijft onderzoek aan andere 
dystrofe diermodellen van groot belang. Naar onze mening verdient 
in dit opzicht in het bijzonder de dystrofe muizestam ReJ 129 dy de 
aandacht, omdat deze zowel klinisch alsook histopathologisch veel 
overeenkomsten vertoont met DMD/BMD. 
De spierdystrofie in de ReJ 129 dy muizestam werd voor het 
eerst beschreven door Michelson en medewerkers in 1955 en erft 
autosomaal recessief over. Het verloop is progressief en leidt tot 
ernstige structurele desorganisatie van de spieren. Dit is met name het 
geval in de achterpootspieren (onder andere het kuitcomplex), waarbij 
de functie compleet wordt verstoord. De dieren overlijden na circa 4 
à 5 maanden veelal aan de gevolgen van infecties. 
In de algemene inleiding, hoofdstuk 1, wordt de 
wetenschappelijke relevantie van deze dy muizestam ReJ 129 dy/dy 
als model voor de humane progressieve spierdystrofie nader 
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toegelicht. Toegelicht wordt dat een defect in de spiervezelmembraan 
de meest waarschijnlijke oorzaak is voor het ontstaan van 
spierdystrofie in deze muizestam. 
Omdat de literatuur een aantal studies kent, die laten zien dat 
de differentiatie en rijping van de skeletspieren in de dy muis zijn 
vertraagd, rijst de vraag of een gestoorde ontwikkeling en/of 
differentiatie deel uitmaakt van het mechanisme dat van het genetische 
defect leidt tot het specifieke phenotype van de dy pathologie. Met 
name derhalve richten we ons in deze studie in de eerste plaats op de 
histologische en histochemische aspecten van de pre- en postnatale 
ontwikkeling en differentiatie van skeletspieren van dystrofe in 
vergelijking met normale muizen. De chronologische expressie van 
spierspecifieke eiwitten wordt bestudeerd in pre- en postnatale stadia 
van de spiervezel ontwikkeling. 
Hoofdstuk 2 geeft een beschrijving van de normale 
spiervezelstructuur (paragraaf 2.2) en biedt een literatuuroverzicht 
over de processen, die zich afspelen bij de ontwikkeling en 
differentiatie van normale skeletspiervezels (paragraaf 2.3). Er wordt 
aandacht besteed aan achtereenvolgens: de moleculaire basis van de 
myogene differentiatie en de factoren, die dit proces beïnvloeden; de 
myoblast-diversiteit en de consequenties hiervan voor het ontstaan van 
verschillende spiervezeltypen; het proces van fusie tussen myoblasten 
en de ontwikkeling van de diverse spiervezeltypen; de ontwikkeling 
en differentiatie van de spiervezel-myofibrillen in relatie tot de 
expressie van cytoskeletaire eiwitten. 
Dit hoofdstuk 2 is tevens bedoeld als een inleiding op de 
hoofstukken 3, 4, en 5, waar de differentiatie en rijping van dystrofe 
spiervezels ten opzichte van normale spiervezels wordt bezien aan de 
hand van verschillende spiervezel-eiwitten. Spiervezel-degeneratie en 
het proces van regeneratie wordt in meer detail bestudeerd in 
hoofdstuk 4. 
Hoofdstuk 3 beschrijft een onderzoek naar de expressie van 
myosine isovormen in de achterpootspieren van normale en dystrofe 
dieren tijdens de postnatale ontwikkeling. Drie isovormen van het 
zware keten myosine, te weten snel ИВ МНС, neonataal МНС en 
langzame I МНС werden immunohistochemisch bestudeerd, gebruik 
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makend van monoclonale antilichamen. De resultaten laten een 
vertraagd verdwijnen zien van neonataal MHC in alle onderzochte 
dystrofe spieren met uitzondering van de soleus. De tijdens de 
normale spierontwikkeling optredende toename van het percentage 
vezels met IIB MHC blijkt te zijn verstoord in dystrofe spieren, 
waarbij een duidelijke fasering vaststelbaar is. Een daling van het 
aandeel IIB vezels is vaststelbaar tijdens de tweede postnatale week, 
d.i. het tijdstip waarop veel vezels necrotizeren; een tweede daling 
treedt op na de 4e postnatale week. 
Hoofdstuk 4 beschrijft een onderzoek naar het voorkomen van 
de cytoskeletaire eiwitten desmine en vimentine in de 
achterpootspieren van normale en dystrofe dieren tijdens de postnatale 
ontwikkeling. Deze intermediaire filament eiwitten werden 
geïdentificeerd en gelocaliseerd gebruik makend van polyclonale 
antilichamen. De resultaten laten zien dat de differentiatie van 
dystrofe spieren, voor wat betreft desmine-expressie en -organisatie, 
normaal verloopt. Verder wordt aangetoond dat zich in dystrofe 
spieren een proces van degeneratie en regeneratie afspeelt, waarbij de 
spiervezels met centrale kernen optreden als het resultaat van een 
proces van regeneratie en niet als gevolg van een defecte rijping, 
zoals in de literatuur wel wordt gesuggereerd. 
Hoofdstuk 5 beschrijft een onderzoek naar de expressie van 
een aantal verschillende spiervezel-eiwitten tijdens de ontwikkeling en 
differentiatie in vitro van normale en dystrofe satellietcellen en 
myotubes. De verschillende spiervezel eiwitten werden 
immunohistochemisch geïdentificeerd, gebruik makend van specifieke 
poly- en monoclonale antilichamen. De resultaten tonen aan dat er 
voor wat betreft de in deze studie gebruikte spiervezel eiwitten geen 
verschillen optreden in de ontwikkeling en differentiatie van normale 
en dystrofe spieren. 
In de inleiding op sectie II wordt kort ingegaan op in de 
literatuur toegepaste experimentele procedures, die de phenotypische 
expressie van de dy dystrofie kunnen beïnvloeden. Naast een aantal 
operatieve technieken, zoals tenotomie en chordotomie, die de 
progressie van het ziekte proces lijken te kunnen remmen of zelfs 
stopzetten, worden ook niet-invasieve methoden toegepast, zoals 
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toegepast, zoals bijvoorbeeld immobilisatie, waarbij beperking van het 
gebruik van de (achterpoot)spieren gedurende een zekere kritische 
periode, leidt tot een betere klinische en morfologische conditie van 
de geïmmobiliseerde spieren. Om de waarneming van een verbeterde 
klinische conditie te kunnen staven met experimenteel-fysiologische 
gegevens wordt de functionele capaciteit van dystrofe spieren 
vergeleken met die van normale spieren. Als immobilisatie techniek 
werd gebruik gemaakt van de procedure ontwikkeld door Wirtz en 
Loermans, om mechanische "overbelasting" van het kuit complex van 
de achterpoot te voorkomen in de voor deze spieren "kritische" 
tweede postnatale week. 
Hoofdstuk 6 beschrijft een onderzoek aan de functionele 
capaciteit van de dystrofe extensor digitorum longus (EDL) spier 
tijdens de postnatale ontwikkeling. De resultaten laten zien dat de 
isometrische contractiekracht van deze spier in situ lager is dan die 
van de normale niet dystrofe EDL op alle onderzochte leeftijdstadia. 
Voorts blijkt dat de contractie- en relaxatietijden van de dystrofe EDL 
enigszins zijn verlengd, ook al zijn de verschillen niet significant. 
In hoofdstuk 7 wordt onderzocht wat de effecten zijn van een 
vroege periode van immobilisatie (8-15 dag postnataal, gevolgd door 
remobilizatie) op de functionele capaciteit van dystrofe spieren op het 
tijdstip van 3 maanden na de ingreep. Onderzocht werden de EDL en 
de tibialis anterior (TA). De resultaten laten zien dat de isometrische 
contractiekracht van de dystrofe en tijdelijk geïmmobiliseerde spieren 
ten opzichte van dystrofe en niet behandelde spieren significant is 
verbeterd. Uit een microscopische evaluatie blijkt tevens dat ook de 
histologie van de behandelde spieren aanmerkelijk minder afwijkend 
is dan die van de niet behandelde, contralaterale spieren. Het aantal 
spiervezels blijkt significant hoger en aanwijzingen voor fibrosering 
ontbreken. 
In hoofdstuk 8 worden een aantal onderwerpen aan de orde 
gesteld, die wegen kunnen aangeven voor verder onderzoek. Als 
eerste wordt ingegaan op de mogelijke celbiologische functie van het 
dystrofine voor de bewaking van de integriteit van de 
spiervezelmembraan tijdens contractie en relaxatie. Een mogelijke rol 
van de recent ontdekte dystrofine-gerelateerde eiwitten (DMDL) in de 
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pathologie van de dy dystrofie wordt bediscussieerd. Vervolgens 
wordt ingegaan op de "gevoeligheid" van dystrofe spiervezels voor 
phenotypische expressie van de aandoening. De redenen voor de 
inductie van de spiervezelnecrose en het verschil in gevoeligheid van 
de diverse vezeltypen voor deze inductie worden bediscussieerd 
uitgaande van de waarneming (Karpati & Carpenter, 1986) dat vezels 
met een kleine diameter als resistent beschouwd moeten worden tegen 
het proces van necrose. Vervolgens wordt het ontstaan van de dy 
pathologie bediscussieerd aan de hand van de 'bone-muscle 
imbalance' hypothese van Totsuka en medewerkers (1983). Deze 
theorie gaat uit van een defecte (=beperkte) groei mogelijkheid van 
de dystrofe spieren tegenover een normale botgroei. Een voortgaande 
verstoring van dit groei-evenwicht verergert het dystrofe proces. Als 
laatste wordt kort ingegaan op het fenomeen van degeneratie en 
regeneratie in de dystrofiërende spieren. Er worden argumenten 
gegeven dat alle vezels met centraal gelegen kernen de resultante zijn 
van een proces van degeneratie gevolgd door regeneratie, hetgeen 
afwijkend is van een van de uitgangspunten, die aan de 'bone-muscle 
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